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CHAPTER 1
INTRODUCTION
INDIRECT BIOSYNTHESIS OF ASN-TRNAASN AND GLN-TRNAGLN IN BACTERIA
Some parts of this chapter have been reproduced with permission from Rathnayake, U.
M. ; Wood, W. N. ; and Hendrickson, T. L. Indirect tRNA aminoacylation during accurate
translation and phenotypic mistranslation. Curr. Opin. Chem. Biol. 2017, 41, 114-122.



These authors contributed equally and are listed in alphabetical order. Copyright © 2017,
Elsevier, reprinted with permission.
1.1 Protein biosynthesis machinery in bacteria
Protein translation is a central, important process in living organisms. First, the
genetic information stored in DNA is transcribed to messenger RNA (mRNA), which is
then decoded by the ribosome to generate a specific amino acid sequence (1-2).
Ribosomal protein translation has two phases (Figure 1.1). In phase I, the cognate tRNA
is paired up with its cognate amino acid by a specific aminoacyl-tRNA synthetase (aaRS)
to produce an aminoacyl-tRNA (aa-tRNA). During phase II, the aa-tRNA forms a ternary
complex with elongation factor Tu (EF-Tu) and GTP and is loaded into the aminoacyl site
(A site) of the ribosome via matching of the mRNA codons to the anticodon of tRNA. Next,
peptide bond formation occurs between the amino acid on the tRNA in the A site of the
ribosome with the growing polypeptide chain in the ribosome’s peptidyl site (P site) (3).
Finally, the fully translated peptide undergoes folding and post-translational modifications
to yield a functional protein.
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Figure 1.1. Bacterial protein translation. (A) Phase I of protein synthesis: tRNA is
aminoacylated with its cognate amino acid in an ATP-dependent manner by the
corresponding aaRS to produce an aa-tRNA. (B) Phase II of protein synthesis: aa-tRNA
assembles in a ternary complex with EF-Tu and GTP and is loaded onto the ribosome for
protein translation (3).
Protein translation is generally carried out with a high level of accuracy: Under lowstress conditions, only 1 out of every 10, 000 mRNA codons is mistranslated (4-5). This
error rate of translation results in ~15% of the proteome containing at least one
misacylated amino acid under normal growth conditions (6-7). Many of these misacylated
proteins are inactive and are degraded after translation. Nevertheless, a small subset of
errors can be advantageous to an organism in stressful environments. This phenomenon
will be discussed later in this chapter.
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1.2 Aminoacyl-tRNA synthetases (aaRSs): mechanisms, classifications, and
editing activities
As mentioned above, the aaRSs play a fundamental role in protein translation:
these enzymes catalyze the aminoacylation of their cognate tRNA(s) with their cognate
amino acid to produce a complete set of aa-tRNA.
1.2.1 Mechanism of aminoacylation
The synthesis of aa-tRNAs occurs in two steps: activation of the amino acid and
linking of it to the cognate tRNA (Figure 1.2). To achieve tRNA aminoacylation, an aaRS
first reacts its cognate amino acid with ATP to generate an enzyme-bound aminoacyladenylate (aa-AMP). In some cases, this step requires binding of tRNA to the aaRS (810). Next, the 2’ or 3’ hydroxyl group of the 3’ adenosine (A76) of the tRNA reacts with
this high-energy aminoacyl-adenylate intermediate to produce the aa-tRNA.

Figure 1.2. Aminoacylation of tRNAs. During tRNA aminoacylation, an aaRS reacts its
substrate amino acid with ATP to generate a high-energy aa-AMP intermediate. Then,
either the 2’ or the 3’ hydroxyl group of the 3’ adenosine of the tRNA reacts with the aaAMP to produce the cognate aa-tRNA.
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1.2.2 Classification of aaRSs
The aaRSs are categorized into two distinct classes: class I and class II. The active
site of class I aaRSs contains an alternating -helical and -sheet arrangement (a
Rossmann fold), while class II aaRSs have a seven-stranded antiparallel -sheet fold.
The class I aaRSs share HIGH and KMSKS signature motifs. Class II aaRSs contains
three signature motifs called motif 1, 2 and 3. Class I aaRSs use their two signature
sequences to recognize ATP and ATP is recognized in an extended conformation. Class
II uses motifs 2 and 3 to bind ATP in a bent configuration. Class I aaRSs are typically
monomeric, whereas class II enzymes tend to be dimeric and oligomerization is driven by
the motif 1 sequence. In class I aaRSs, tRNA aminoacylation typically occurs at the 2’
hydroxyl group of the terminal (A76) tRNA. In contrast, esterification occurs at the 3’
hydroxyl group of the terminal tRNA in class II enzymes. The class I aaRSs binds the
acceptor stem of the tRNA on the minor groove side and class II aaRSs binds on the
major groove side (11-14). These differences among the class I and class II aaRSs are
summarized in Table 1.1. The two classes of aaRSs can be further divided into
subclasses based on their structural and functional peculiarities (Table 1.2).
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Table 1.1. Main features of the two classes of aaRSs.
Class I

Class II

Conserved signature
motifs1

•
•

Active site fold
ATP binding
tRNA recognition
Aminoacylation site

Rossmann fold
Extended
Minor groove
2’ hydroxyl group

1 Lower

HiGh
kmSKs

• motif 1: gxxxxP
• motif 2: fRxe
• motif 3: gxgxgxfd/eR
Antiparallel -sheets
Bent
Major groove
3’ hydroxyl group

case letters represent less conserved residues and  indicates a requirement for

a hydrophobic amino acid.
Table 1.2. The two classes of aaRSs.
Class I
Class Ia

Class II
Class IIa
AlaRS1
GlyRS1
HisRS
ProRs
SerRS
ThrRS

ArgRS
CysRS
IleRS
LeuRS
MetRS
ValRS
Class Ib

Class IIb
GluRS
GlnRS
LysRS2

Class Ic

Class IIc
TrpRS
TryRS

1 AlaRS

AspRS
AsnRS
LysRS2
PheRS

and GlyRS have been classified as class IIa (12) by some and as class IIc by

others (11, 15). Here we represent it as class IIa according to reference (12).
2 LysRS

can be classified into both classes. Class I LySRS if found in a few bacteria and

mainly in archaea (12).
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1.2.3 aaRSs editing activities
Generally, protein synthesis needs to be carried out with high accuracy and fidelity.
The aaRSs play an important part in this regard by discriminating between the cognate
and noncognate amino acid and tRNA substrates. Errors in amino acid recognition by the
aaRSs is higher than that of tRNA recognition (11), due to the size and complexity
differences between amino acid and tRNAs. While amino acids are smaller and less
complex in nature, tRNAs are bigger and contain greater structural diversity. For example,
argininyl-tRNA synthetase (ArgRS) can discriminate its cognate tRNAArg over tRNAAsp by
about 10,000-fold (16). In contrast, isoleucyl-tRNA synthetase (IleRS) can only
discriminate its cognate amino acid isoleucine from its noncognate amino acid substrate
valine by ~ 180-fold (17-19). However, mistakes in amino acid recognition are not typically
carried into proteins because of proofreading mechanisms.
Both class I and class II aaRSs exhibits proofreading/editing mechanisms called
pre- and post-transfer editing (Figure 1.3) (11, 15, 20). These activities eliminate the noncognate amino acids that are used during aminoacylation. Pre-transfer editing is the
hydrolysis of the noncognate aa-AMP intermediate. Pre-transfer editing can occur in three
different ways: enzyme-catalyzed hydrolysis; tRNA-mediated, enzyme-catalyzed
hydrolysis; and non-enzymatic hydrolysis of the aa-AMP after release from the enzyme
(21). If the noncognate amino acid is transferred to the tRNA, then the 3’ end of the
misacylated aa-tRNA is translocated into the editing site of the aaRS (typically ~25-30 Å
away from the active site) where it undergoes enzyme-catalyzed hydrolysis (post-transfer
editing) (22-24).
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The lower errors observed in the recognition of a non-cognate tRNAs by aaRSs is
accomplished by several mechanisms. tRNAs contain several structural elements called
identity elements that are used by the aaRS to favor specific recognition of the cognate
tRNA. Some tRNAs also contain anti-determinants that acts as negative elements and
prevent tRNA binding to non-cognate aaRSs (7, 15, 25). Post-transcriptionally modified
nucleotides, such as queuosine and 2-thiouridine, also play important roles in tRNA
selection (26-27).
1.3 Direct and indirect tRNA aminoacylation
When the aaRSs were first discovered, it was believed that there would always be
20 aaRSs in each organism, with one enzyme for each aa-tRNA isoacceptor set.
However, this rule of 20 aaRSs for 20 amino acids is only true in the cytoplasm of
eukaryotes (e.g. yeast (28) and humans (29)) and some microorganisms (e.g.
Escherichia coli (E. coli) (30)). This phenomenon is not true for most bacteria (31), most
archaea (32) and eukaryotic organelles (chloroplasts, mitochondria) (33). Organisms that
diverge from this rule follow an indirect tRNA aminoacylation pathway and utilize
noncanonical aaRSs to compensate for the activity of missing, canonical aaRSs.
1.3.1 Direct tRNA aminoacylation pathway
The organisms that contain a full set of 20 aaRSs can directly aminoacylate all
tRNAs with their cognate amino acids to produce a complete set of aa-tRNAs. For
example, glutaminyl-tRNA synthetase (GlnRS) aminoacylates tRNAGln with glutamine to
produce Gln-tRNAGln directly, and asparaginyl-tRNA synthetase (AsnRS) can pair up
tRNAAsn with asparagine to produce Asn-tRNAAsn (Figure 1.4A and B, top arrows).

8

Figure 1.3. Aminoacylation and editing activity of the aaRSs. aaRSs aminoacylate
their cognate tRNAaa with their cognate amino acid (aa) to produce aa-tRNAaa. Usually,
the aaRSs can select their cognate substrates from a substrate pool that contains similar,
non-cognate species. Occasionally, non-cognate amino acids (xx) are misactivated by an
aaRS. In these cases, the non-cognate amino acid (xx) can be removed by hydrolysis of
the xx-AMP (pre-transfer editing) or the xx-tRNA (post-transfer editing).
1.3.2 Indirect tRNA aminoacylation pathways
Organisms that do not have a full set of aaRSs utilize an indirect biosynthesis
pathway to produce the aa-tRNAs that correspond to the missing aaRSs. In these
species, additional enzymes are required to generate these cognate aa-tRNA pairs.
AsnRS, GlnRS, and cysteinyl-tRNA synthetase (CysRS) are the aaRSs that are known
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to be missing from different microorganisms, and AsnRS and GlnRS are actually quite
uncommon among microorganisms (34). Thus, indirect biosynthesis pathways are used
to generate Asn-tRNAAsn, Gln-tRNAGln, and Cys-tRNACys (35-39). Further, indirect
pathways are also used in producing non-standard aa-tRNAs, such as selenocysteinyltRNASec and pyrrolysyl-tRNAPyl (34).
1.3.2.1 Indirect biosynthesis of Gln-tRNAGln
Indirect tRNA aminoacylation was first discovered in Bacillus subtilis (B.subtilis) in
the late 1960s (40). B. subtilis lacks GlnRS and cannot directly produce Gln-tRNAGln
(Figure 1.4B, top arrow).(40-42) Instead, Gln-tRNAGln is synthesized via the indirect
tRNA aminoacylation pathway. First, tRNAGln is misacylated with glutamate to produce
Glu-tRNAGln. This reaction is catalyzed by a non-discriminating glutamyl-tRNA synthetase
(ND-GluRS) or GluRS2 (a tRNAGln-specific GluRS) (40-42). Next, this misacylated
intermediate Glu-tRNAGln is transamidated by an amidotransferase called AdT (GatCAB
or GatDE, described in further detail below) to generate Gln-tRNAGln (Figure 1.4B,
bottom arrow) (34, 37-38, 43). ND-GluRS can glutamylate both tRNAGln and tRNAGlu
with glutamate to produce Glu-tRNAGln and Glu-tRNAGlu, respectively. Some organisms
contain two divergent glutamyl-tRNA synthetases: GluRS1 and GluRS2 (41-42). For
example, in Helicobacter pylori (H. pylori), GluRS1 acts as a discriminating GluRS and
aminoacylates tRNAGlu to generate Glu-tRNAGlu. In contrast, GluRS2 is used specifically
in the indirect biosynthesis of Gln-tRNAGln, and it misacylates tRNAGln with glutamate to
produce Glu-tRNAGln; GluRS2 does not produce Glu-tRNAGlu (42).
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1.3.2.2 Indirect biosynthesis of Asn-tRNAAsn
The indirect biosynthesis of Asn-tRNAAsn is analogous to the above-mentioned
indirect production of Gln-tRNAGln pathway. In organisms that lack AsnRS and/or
asparagine synthetase (AsnS), non-discriminating aspartyl-tRNA synthetase (NDAspRS) aminoacylates both tRNAAsp and tRNAAsn with aspartate to produce Asp-tRNAAsp
and Asp-tRNAAsn, respectively (35, 43). The misacylated Asp-tRNAAsn is then converted
to Asn-tRNAAsn by AdT (Figure 1.4A, bottom arrow) (34, 37, 44-45). In some species,
which lack AsnS, this indirect pathway is the sole biosynthetic route to asparagine.
Since AsnRS is more abundant than GlnRS, the indirect biosynthesis of AsntRNAAsn is less common in organisms compared to the corresponding pathway producing
Gln-tRNAGln (16). Further, compared to Gln-tRNAGln biosynthesis, in the indirect
production of Asn-tRNAAsn, the second step is only catalyzed by

GatCAB, as the

intermediate Asp-tRNAAsn cannot be recognized by GatDE (38).
The work presented in this dissertation is focused on three different pathogenic
bacteria: H. pylori, Mycobacterium smegmatis (M. smegmatis), and Staphylococcus
aureus (S. aureus). These organisms all utilize indirect tRNA aminoacylation to produce
both Asn-tRNAAsn and Gln-tRNAGln (46-48). H. pylori and M. smegmatis lack genes
encoding both GlnRS and AsnRS and use indirect tRNA aminoacylation to produce both
Asn-tRNAAsn and Gln-tRNAGln (42, 49-50). Since H. pylori do not contain a functional
AsnS, this pathway is also essential as a source of asparagine. In contrast, S. aureus
lacks GlnRS and AsnS but has AsnRS. Thus S. aureus produces Gln-tRNAGln by indirect
tRNA aminoacylation only but can produce Asn-tRNAAsn directly and indirectly. The latter
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pathway is necessary for asparagine biosynthesis (51). Table 1.3 summarize the gene
distribution of these organisms.
Table 1.3. AsnRS, AsnS and GlnRS gene distribution of H. pylori, M. smegmatis,
and S. aureus.
Organism
H. pylori
M. smegmatis
S. aureus

AsnRS
×
×
✓

AsnS
×
✓
×

GlnRS
×
×
×

Figure 1.4. Direct and indirect biosynthesis of Asn-tRNAAsn and Gln-tRNAGln in
bacteria. (A) Biosynthesis of Asn-tRNAAsn: direct biosynthesis (top arrow), and GatCABcatalyzed indirect biosynthesis (bottom arrow). (B) Biosynthesis of Gln-tRNAGln: direct
biosynthesis (top arrow), and GatCAB-catalyzed indirect biosynthesis (bottom arrow). ND
stands for non-discriminating.
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1.4 Discriminating and non-discriminating AspRS
In chapter 3, we discuss our discovery of an unusual and unexpected behavior in
some bacterial AspRSs, namely the fact that these enzymes can produce Glu-tRNAGlu.
This section of the introduction will focus more on the gene distribution of AspRSs in
bacteria and the reactions catalyzed by AspRS and ND-AspRS.
Based on their tRNA substrate specificities, AspRS is found in two forms:
discriminating, which produces Asp-tRNAAsp (16, 52), and non-discriminating, which
produces both Asp-tRNAAsp and Asp-tRNAAsn (35, 43, 52). In the latter case, the
misacylated Asp-tRNAAsn is converted to Asn-tRNAAsn by GatCAB (36-37). Most
organisms contain one genetic copy of AspRS, defined to be either discriminating (as in
E. coli (53)) or non-discriminating (as in H. pylori (49), M. smegmatis (50), S. aureus (51)),
However, some contain two different copies of AspRS, wherein one is typically
discriminating and the other is non-discriminating (e.g. Thermus thermophilus (T.
thermophilus (54)), Deinococcus radiodurans (D. radiodurans (45)), and Clostridium
acetobutylicum (C. acetobutylicum (55)). In these cases, the long bacterial-type AspRS
is discriminating and catalyzes the synthesis of Asp-tRNAAsp. The additional AspRS is
non-discriminating and produces both Asp-tRNAAsn along with Asp-tRNAAsp. The NDAspRS is of archaeal origin and was acquired through horizontal gene transfer (56). Table
1.4 list examples of bacteria with different types of AspRSs and the major Asn-tRNAAsn
biosynthesis pathway in these organisms.
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Table 1.4. AspRS, AsnRS, AsnS and GatCAB gene distribution in bacteria.
Organism

AspRS1 AsnRS AsnS

GatCAB

Escherichia coli

D

+

+

-

Lactobacillus
bulgaricus

D

+

+

+

Notes
• Utilizes direct route to

produce Asn-tRNAAsn

Ref.
(53)

• AspRS is

discriminating even in
the presence of AdT

(57)

• AspRS is non-

Bacillus subtilis
ND

+

+

+

Bacillus
halodurans

discriminating although
organisms have
AsnRS and AsnS
• Utilize both direct and
indirect routes to
synthesize AsntRNAAsn

Staphylococcus
aureus
Legionella
pneumophila

(56)

(51)
ND

+

-

+

• Synthesize asparagine

from Asp-tRNAAsn
(58)

Bdellovibrio
bacteovorus
Mycobacterium
tuberculosis

• Uses indirect tRNA

ND

-

+

+

Mycobacterium
smegmatis
Pseudomonas
aeruginosa

• Asparagine

ND

-

-

+

Helicobacter
pylori
Thermus
thermophilus

1D
1 ND

Deinococcus
radiodurans

1D
1 ND

Clostridium
acetobutylicum

1D
2 ND

1 The

aminoacylation to
produce Asn-tRNAAsn

biosynthesis is tRNA
dependent
• Contain multiple copies

+

-

+

of AspRS
• Long bacterial-type
AspRS is
discriminating
• Additional AspRS is
non-discriminating and
of archaeal origin

(50)

(59)
(49)
(54)
(45)
(55)

nature of AspRS is represented as follows: D is for discriminating and ND is for nondiscriminating.
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1.5 GatCAB, bacterial glutamine-dependent amidotransferase
In organisms that use the indirect tRNA aminoacylation pathway, the misacylated
intermediates Asp-tRNAAsn and Glu-tRNAGln need to be transamidated to Asn-tRNAAsn
and Gln-tRNAGln, respectively. AdT catalyzes the efficient conversion of these
misacylated tRNAs to their correctly acylated forms (34). AdT can be found in two different
forms: the heterotrimeric GatCAB in bacteria, some archaea, and in some organelles (36,
44, 60-61) and the heterodimeric GatDE, which is confined to archaea (38, 61-62). While
GatCAB is bi-functional and catalyzes the amidation of both Asp-tRNAAsn and Glu-tRNAGln
into Asn-tRNAAsn and Gln-tRNAGln respectively, GatDE is mono-functional and only
catalyzes the conversion of Glu-tRNAGln into Gln-tRNAGln (61). Since we study the
bacterial indirect tRNA aminoacylation systems, henceforth we will emphasize the
structure and mechanism of the bacterial GatCAB.
As mentioned above, bacterial GatCAB can recognize both Asp-tRNAAsn and GlutRNAGln and transamidate these into Asn-tRNAAsn and Gln-tRNAGln using glutamine as an
ammonia donor (34, 36). The bacterial GatCAB is a heterotrimeric protein composed of
three subunits: GatA, GatB, and GatC, with two active sites located in GatA and GatB
that are ~40 Å apart (60). GatCAB achieves transamidation by catalyzing three discreet
reactions:

glutamine

hydrolysis,

phosphorylation

of

misacylated

tRNA,

and

transamidation of the phosphorylated misacylated tRNA into correctly aminoacylated
tRNA (Figure 1.5, shown only for Gln-tRNAGln biosynthesis). GatA hydrolyzes
glutamine to produce glutamate and ammonia (Figure 1.5A). The ammonia is then
delivered to the active site of GatB through an ammonia tunnel (which will be discussed
in detail later). The GatB subunit catalyzes ATP-dependent phosphorylation of Asp-
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tRNAAsn and Glu-tRNAGln to phosphoryl-Asp-tRNAAsn and phosphoryl-Glu-tRNAGln
(Figure 1.5B) (63-64). Next, GatB catalyzes the transamidation of these two
phosphorylated tRNAs to produce Asn-tRNAAsn or Gln-tRNAGln using the ammonia
produce by GatA (Figure 1.5C) (36).

Figure 1.5. The three reactions catalyzed by GatCAB. Reactions are only shown for
Gln-tRNAGln production. (A) Glutamine hydrolysis by GatA to produce glutamate and
ammonia. (B) Phosphorylation of Glu-tRNAGln to phosphoryl-Glu-tRNAGln, by GatB. (C)
Transamidation of phosphoryl-Glu-tRNAGln to Gln-tRNAGln by GatB using the ammonia
generated by GatA.
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Many glutamine-dependent aminotransferases (GATs) contains molecular tunnels
to deliver the ammonia produced in their glutaminase active sites to downstream
transamidase active sites. Most of the ammonia tunnels reported so far are largely
hydrophobic (65-68) and assumed to deliver ammonia in its neutral, deprotonated form
by passive transportation (69). In contrast, GatCAB’s ammonia tunnel is largely
hydrophilic, lined with polar ionic amino acids, and populated with ordered water
molecules (60).
Using the S. aureus GatCAB crystal structure, two ammonia tunnels have been
proposed: tunnel I (60) and tunnel II (70). Tunnel I is lined with conserved acid/base
residues and it has been proposed that ammonia delivery occurs through a series of
protonation and deprotonation steps (60). Tunnel II (70) is slightly different from than
tunnel I. These two tunnels have different paths starting at a highly conserved aspartate
in GatA. While tunnel I is lined with hydrophilic amino acids, the top of tunnel II is lined
with hydrophobic residues. The two tunnels merge into one ~10 Å past the active site of
GatA, and the rest of the tunnel is hydrophilic in nature. Mutational work on H. pylori
GatCAB (71) and free energy calculations with S. aureus GatCAB (72) suggest that tunnel
I is more functionally relevant than tunnel II.
A kinetic analysis of tunnel I mutants in H. pylori GatCAB with molecular dynamics
simulations using S. aureus GatCAB indicate apparent domain-domain communication
between GatA and GatB (71). Recent work characterizing the conserved aspartate
(D185A) in H. pylori, located only in tunnel I, further support the idea that tunnel I is the
physiologically relevant tunnel (73). D185A and D185N GatCAB mutants completely
disrupted transamidase activity with lower glutaminase activity and kinase activity
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compared to WT GatCAB. In comparison, the D185E mutant had wild-type activity. These
results demonstrated that D185 is integral to ammonia transport in GatCAB and is the
first example of an acid/base residue in an ammonia tunnel (73).
1.6 Macromolecular transamidosome complexes in indirect tRNA aminoacylation
Elongation factor Tu (EF-Tu) plays an important role in maintaining the fidelity of
protein biosynthesis by differentiating against the misacylated Asp-tRNAAsn and GlutRNAGln in favor of the cognate Asn-tRNAAsn and Gln-tRNAGln (74). However,
discrimination by EF-Tu is not sufficient to prevent aspartate and glutamate
misincorporation into proteins at asparagine and glutamine codons, respectively (50, 7476). Thus, additional mechanisms to sequester both misacylated tRNAs from EF-Tu and
the ribosome must exist. The most straightforward solution is to deliver each misacylated
tRNA directly from its misacylating aaRS to GatCAB (33). In fact, it is now clear that an
Asn-transamidosome, composed of ND-AspRS, GatCAB, and either tRNAAsn (77-78) or
a protein called Hp0100 (79), is critical for efficient Asn-tRNAAsn production and
sequestration of Asp-tRNAAsn away from EF-Tu and the ribosome. These complexes
have been predominantly characterized in vitro, however, their stability and ease of
formation support their in vivo importance. Evidence also exists for the formation of an
analogous Gln-transamidosome (80-81), although a clear demonstration of functional
relevance has remained elusive. Tables 1.5 and 1.6 and the following sections describe
our current understanding of the formation and function of Asn-transamidosome and Glntransamidosome complexes.
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1.6.1 The Asn-transamidosome
The first Asn-transamidosome was reconstituted in vitro from T. thermophilus
components (77). The crystal structure of this complex contains two dimeric ND-AspRS,
two copies of GatCAB, and four copies of tRNAAsn (82). Assembly of the T. thermophilus
Asn-transamidosome requires tRNAAsn. Two copies of tRNAAsn are productively bound to
the GatB active site, while the other two serve as scaffolds for the complex. Based on this
structure, the authors proposed a convincing model for simple rotation of the 3’ acceptor
end of tRNAAsn to allow the transfer of Asp-tRNAAsn from the ND-AspRS active site to the
GatB transamidation active site without dissociation from the complex, thus sequestering
Asp-tRNAAsn from EF-Tu and the ribosome. Consistent with this model for sequestration,
this Asn-transamidosome complex protects the labile ester of Asp-tRNAAsn (1.4–2-fold)
from hydrolysis (77).
A crystal structure of the Pseudomonas aeruginosa (P. aeruginosa) Asntransamidosome has also been reported (78). The P. aeruginosa structure is different
from that of T. thermophilus, even though both require tRNAAsn to assemble. The P.
aeruginosa Asn-transamidosome contains two copies of GatCAB, two copies of tRNAAsn,
and one copy of the ND-AspRS homodimer. In this case, both tRNAs are bound
productively to the two GatB active sites. The differences in these two structures likely
arise from the evolutionary origin of their respective ND-AspRSs: T. thermophilus uses
an archaeal-type ND-AspRS (77), whereas P. aeruginosa uses a bacterial type (78). The
bacterial-type ND-AspRS contains a GAD domain that is missing in the archaeal-type
enzyme. This P. aeruginosa GAD domain forces GatCAB into a different position than
that observed in the T. thermophilus structure (78). It is also possible that some of these
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structural differences reflect adaptation to the different optimal growth temperatures of
these two organisms (37 °C vs. 65 °C).
The H. pylori Asn-transamidosome has been characterized in vitro (79, 83), but a
crystal structure of this complex has not yet been reported. This complex is also distinct
from those of T. thermophilus and P. aeruginosa. Initial characterization demonstrated
the formation of a more dynamic, tRNAAsn-dependent, H. pylori Asn-transamidosome
(83). The size of this complex, and consequently its overall integrity, was sensitive to the
presence or absence of different substrates for indirect tRNA aminoacylation (e.g. Laspartate, L-glutamine, and ATP). A subsequent study showed that a novel protein
partner called Hp0100 drives the formation of a stable H. pylori Asn-transamidosome,
even in the absence of tRNAAsn. The addition of Hp0100 increases the rate of GatCABcatalyzed transamidation of Asp-tRNAAsn to Asn-tRNAAsn by approximately 35-fold but
has no effect on ND-AspRS activity (79). It is not clear yet why only some bacteria have
incorporated Hp0100 into the Asn-transamidosome, displacing a requirement for tRNAAsn
for complex assembly. The identification of Hp0100 raises the tantalizing possibility that
other proteins involved in indirect tRNA aminoacylation remain undiscovered.
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Table 1.5. Asn-transamidosome complexes. (Cartoons adapted from that given in
reference (78)).
Organism

T. thermophilus

H. pylori

P. aeruginosa

Structure

Composition

• 2 ND-AspRS
dimers
• 2 GatCAB
• 4 tRNAAsn

• ND-AspRS
• GatCAB
• Hp0100
• Complex
stoichiometry
unknown

• 1 dimeric NDAspRS
• 2 GatCAB
• 2 tRNAAsn

tRNAAsn-dependent

tRNAAsn-independent

tRNAAsn-dependent

Only two ND-AspRS
monomers are active No effect on NDat a given time (out
AspRS activity
of four)

Additional
information
and
observations

Complex increases
ND-AspRS activity

Hp0100 had no effect Complex increases
on ND-AspRS activity ND-AspRS activity

Decreases GatCAB
activity with AsptRNAAsn
Protects AsptRNAAsn and AsntRNAAsn from
hydrolysis
Four tRNAAsn are
bound in two forms:
catalytic and scaffold

Hp0100 increases
GatCAB activity with
Asp-tRNAAsn

ND

ND

Rapidly releases
Asn-tRNAAsn

Crystal structure
available
References

Both ND-AspRS
monomers are active

(77, 82)

Two tRNAAsn are
tRNA stoichiometry is
bound in productive
unknown
conformations
Crystal structure
available

ND
(79, 83)

(78)
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1.6.2 The Gln-transamidosome
With the demonstration of different, functional Asn-transamidosome complexes, it
is logical to assume that an analogous Gln-transamidosome is also important for
sequestering Glu-tRNAGln from EF-Tu and ribosomes and/or promoting efficient
production

of

Gln-tRNAGln.

However,

to

date,

the

characterization

of

Gln-

transamidosomes has proven to be more challenging. In vitro characterization of a
bacterial transamidosome from Thermotoga maritima (T. maritima) has been reported to
be tRNAGln-dependent (81). In an electrophoretic mobility shift assay, Glntransamidosome formation was observed upon equimolar titration of both ND-GluRS and
GatCAB (0–100 M) with constant tRNAGln (2 M). A crystal structure of this complex was
obtained by expressing the GatC subunit of GatCAB and ND-GluRS as a single
polypeptide chain, connected by a short peptide linker. In this structure, the tRNA Gln is
bound to ND-GluRS in a manner suitable for aminoacylation but not transamidation (81).
Thus, this structure does not offer the same satisfying explanation for facile transfer of
Glu-tRNAGln from ND-GluRS to GatCAB that is observed in the T. thermophilus Asntransamidosome structure. Efforts to isolate a functional, H. pylori Gln-transamidosome
identified a narrow range of tRNAGln concentrations where complex formation was
observed, suggesting that this complex is highly dynamic (80).
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Table 1.6. Gln-transamidosome complexes. (Cartoons adapted from that given in
reference (78)).
Organism

T. maritima

H. pylori

Structure

Composition

Additional
information
and
observations

References

• 1 ND-GluRS
• 1 GatCAB
• 1 tRNAGln

• 1 GluRS2
• 1 GatCAB
• 1 tRNAGln

tRNAGln-dependent

tRNAGln-dependent

ND-GluRS is
Complex assembly forms
functionally bound to
over a small range of
Gln
tRNA
tRNAGln concentrations
GatCAB is bound to
tRNAGln in a nonND
productive conformation
No apparent mechanism
for Glu-tRNAGln transfer
ND
between enzymes
GatC and ND-GluRS
are covalently linked in
ND
the crystal structure
(81)

(80)
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1.6.3 Asn-transamidosomes versus Gln-transamidosomes: Current understanding
and future directions
The Gln-transamidosomes characterized to date (80-81) appear to be generally
less stable and more dynamic than known Asn-transamidosomes (77-79, 82-83). Further,
in the structure of the T. thermophilus Asn-transamidosome, Asp-tRNAAsn is positioned
for facile transfer from the catalytic site of ND-AspRS to the GatB transamidation site,
without disruption of the complex (82). This transfer is achievable because ND-AspRS
and GatCAB recognize different faces of the acceptor stem of tRNA Asn, with ND-AspRS
binding from the major groove side and GatCAB from the minor groove side (82). This
elegant solution cannot be achieved in a complex between ND-GluRS (or GluRS2) and
GatCAB, because these enzymes all bind the minor groove face of tRNA Gln and
consequently compete for recognition of this substrate (81). With the current Glntransamidosome structure available, it seems that these complexes must either
dissociate or go through a series of undefined movements to facilitate sequestration and
transamidation of Glu-tRNAGln (81).
The utilization of Asn-transamidosome complexes in bacteria provides a tidy
solution for maintaining accuracy at asparagine codons in organisms that lack AsnRS.
Careful work characterizing Gln-transamidosome complexes in vitro has also led to
important insight, but without as satisfying a conclusion, because a mechanism for
sequestering Glu-tRNAGln and transferring it from ND-GluRS to GatCAB has not yet
emerged. In this regard, the possibility that other currently unknown proteins may drive
Gln-transamidosome assembly, analogous to the role played by Hp0100 in the H. pylori
Asn-transamidosome (79), might provide an answer. Moreover, the likelihood of the
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formation of a larger complex containing both ND-AspRS and ND-GluRS, with GatCAB
and either or both tRNAs has not yet been investigated. Little is known about the
dynamics of GatCAB in vivo as it works concomitantly to produce both Asn-tRNAAsn and
Gln-tRNAGln. Does this enzyme exist simultaneously in two distinct Asn-transamidosome
and Gln-transamidosome complexes? Or, is there a mega Asn/Gln-transamidosome in
species that lack both AsnRS and GlnRS? The mechanisms through which this dual
action is achieved are certain to prove interesting.
1.7 Inducing mistranslation as a stress response by disrupting indirect tRNA
aminoacylation
Evidence is accumulating that bacteria can induce mistranslation under times of
stress, such that heterogeneous proteins are formed (84-85). Many of these proteins are
inactive and degraded. However, a small subpopulation of mutated proteins may exhibit
new functions within this statistical proteome, which can be advantageous to an organism,
particularly if they provide an immediate persistence or survival mechanism against a
given environmental stress. Because indirect tRNA aminoacylation proceeds via two
misacylated tRNA intermediates, Asp-tRNAAsn and Glu-tRNAGln, the possibility that
mistranslation at asparagine and/or glutamine codons would be upregulated under stress
conditions has recently received attention with interesting results.
The first hint that mistranslation at asparagine and glutamine codons could provide
a phenotypic advantage came from work in M. smegmatis (50). M. smegmatis tRNAAsp
and tRNAGlu were mutated to contain asparagine and glutamine anticodons. The tRNAAsp
anticodon was mutated from
from

34CUC

to

34GUC

34CUG

and from

to 34UUG. Two tRNAGlu isoacceptors were mutated,

34CUU

to

34GUU.

The Mycobacteria lack genes for both
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AsnRS and GlnRS; and, ND-AspRS and ND-GluRS were capable of misacylating these
mutant tRNAs to produce Asp-tRNAAsp(34UUG), Glu-tRNAGlu(34GUC), and Glu-tRNAGlu(34GUU).
When these tRNAs were overexpressed, tolerance of cell cultures to the antibiotic
rifampicin increased by nearly three orders of magnitude. Only weak tolerance against
isoniazid and no tolerance to ciprofloxacin was noted. This rifampicin tolerance was
traced to alterations in RNA polymerase (RNAP) activity, which showed diminished
antibiotic sensitivity to rifampicin. The authors proposed that mistranslation of glutamate
to glutamine and/or aspartate to asparagine in the rifampicin resistance-determining
region (RRDR) of the -subunit of RNAP led to this specific tolerance to rifampicin. These
results were the first to suggest that indirect tRNA aminoacylation could be perturbed to
promote mistranslation as a method to achieve specific phenotypic responses against
antibiotics (50).
The experiments above used a strain of M. smegmatis that had been modified to
overexpress non-native tRNA hybrids (tRNAAsp with an asparagine codon and two
different tRNAGlu isoacceptors, both with glutamine codons) (50). A connection between
indirect tRNA aminoacylation, mistranslation, and phenotypic resistance was discovered
in M. smegmatis and clinical strains of Mycobacterium tuberculosis (M. tuberculosis) (76).
The application of two clever, in vivo, forward genetic screens for mistranslation at
asparagine and glutamine codons (using native tRNAs) led to the identification of three
mutations in GatA (A10T, V405D, and a three-residue deletion DTAL295–297, M.
smegmatis numbering) that induced increased tolerance to rifampicin even when
transplanted into clean genetic backgrounds. A database search of clinically relevant
strains and analysis of clinical samples identified additional GatA mutations in M.
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tuberculosis (P143T, A9T, G444S, and K61N, M. tuberculosis numbering) that also
showed increased rifampicin tolerance. Exhaustive characterization of these mutations
from both organisms clearly demonstrated higher levels of mistranslation and rifampicinspecific phenotypic resistance (RSPR) (Figure 1.6). The authors postulated that this
RSPR is due to specific mistranslation of aspartate for asparagine at N434 in the subunit of M. smegmatis RNAP (N437 in M. tuberculosis RNAP), a position known to be
important for rifampicin binding (76). In our opinion, the importance of this work cannot
be overstated as it offers the first direct evidence for coopting of indirect tRNA
aminoacylation to promote mistranslation in response to stress in a critically important
human pathogen. It seems probable that similar phenotypic response mechanisms are
used outside of the Mycobacteria, although this possibility remains to be seen.
The above work led to the identification of five mutations and a small deletion in
GatA, all of which increase the ability of mycobacteria to resist rifampicin (76).
Remarkably, these mutations are all found on the surface of GatA far from its active site
or interactions with either GatB or GatC. These mutations decrease the stability of GatA
and GatB in vivo leading Javid and coworkers to propose that they induce mistranslation
by disrupting the GatCAB heterotrimeric complex (76). It is also possible that they perturb
GatCAB activity or disrupt the formation of either the Asn-transamidosome or Glntransamidosome. Additional characterization of these mutations to determine their
functional consequences will certainly provide further insight into their mechanism(s) of
action.
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Figure 1.6. Mutations in GatCAB cause mistranslation and induce RSPR in
Mycobacteria. Mutations in GatCAB were identified that increase mistranslation at
asparagine and glutamine codons (shown for asparagine only). This mistranslation leads
to increased tolerance to rifampicin.
1.8 Hp0100, a component of the H. pylori Asn-transamidosome
After years of research dedicated to characterizing the H. pylori Asntransamidosome composed of tRNAAsn, ND-AspRS, and GatCAB were unsuccessful (80,
83), in an effort to find an alternative strategy for Asn-transamidosome assembly and
function, data-mining of a published yeast-two-hybrid (Y2H) interaction profile of the H.
pylori proteome led our lab to discover a protein of unknown function called Hp0100 (79,
86). In this interaction profile, the likelihood of a protein-protein interaction being
physiologically relevant was given a letter score: a score of A indicates an interaction that
is likely to be physiologically important, and a score of E was given to observed
interactions that were predicted to be artifactual. In this screen, Hp0100 showed a B level
interaction with ND-AspRS and a weak, D level interaction with GatCAB (Figure 1.7).
Since ND-AspRS and GatCAB are closely-intertwined functional components of the
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indirect tRNA aminoacylation pathway and Hp0100 shows interactions with both proteins,
our lab further investigated Hp0100 as a possible protein partner in the formation of a
transamidosome complex in H. pylori.

Figure 1.7. Yeast-2-hybrid interaction profile of Hp0100. Hp0100 show a B level
interaction with ND-AspRS and a D level interaction with GatCAB. Data acquired from
(86).
Dr. Gayathri Silva demonstrated that Hp0100 is an essential component of a tRNA
independent Asn-transamidosome in H. pylori (Figure 1.8) (79, 87). In the proposed
catalytic Asn-transamidosome cycle, ND-AspRS, GatCAB, and Hp0100 first assemble
into a stable apo-transamidosome. A holo-transamidosome is formed that includes
tRNAAsn. ND-AspRS aminoacylates tRNAAsn to form misacylated Asp-tRNAAsn, which is
then converted to Asn-tRNAAsn by GatCAB. Finally, the correctly aminoacylated AsntRNAAsn is released to regenerate the apo-transamidosome (79).
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Figure 1.8. Proposed H. pylori Asn-transamidosome cycle. GatCAB, ND-AspRS, and
Hp0100 assemble into an apo-transamidosome and tRNAAsn is recruited to form the holotransamidosome. After the production of misacylated Asp-tRNAAsn by ND-AspRS, the
product gets transamidated by GatCAB and released as Asn-tRNAAsn from the complex
regenerating the apo-transamidosome. Figure regenerated with permission from the
Journal of Biological Chemistry (79).
Further, Dr. Silva found that Hp0100 enhances the GatCAB-catalyzed
transamidation of both Asp-tRNAAsn and Glu-tRNAGln: the addition of Hp0100 to GatCAB
reactions enhances the observed rate of Asp-tRNAAsn transamidation to Asn-tRNAAsn by
~35 fold (79) and of Glu-tRNAGln to Gln-tRNAGln by ~3 fold (87) (Figure 1.9). Hp0100
does not impact ND-AspRS aminoacylation activity (87).
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Figure 1.9. Hp0100 accelerates GatCAB-catalyzed transamidation of misacylated
tRNAs. Hp0100 accelerates the transamidation of Glu-tRNAGln to Gln-tRNAGln by ~3-fold
(left) (87) and Asp-tRNAAsn to Asn-tRNAAsn by GatCAB by ~35-fold (right) (79). Figure
provided by Dr. Gayathri Silva.
Conserved domain analysis identified two putative ATPase domains, one built from
an -adenosine nucleotide hydrolase (AANH) domain and the second from a P-loop motif
(Figure 1.10A) (88). Encouragingly, the model structure of Hp0100 (generated by
Rosetta (89)) was built from the argininosuccinate synthetase structure that also contains
an AANH domain (90-91). AANH domain proteins contain an alpha-beta-alpha fold and
generally hydrolyze ATP to AMP and PPi (88, 90). P-loop proteins have a consensus
sequence of GXXXXGK[S/T] and hydrolyze ATP to ADP and Pi (92-93). Using TLC and
an enzyme-coupled assay specific for ADP detection, Dr. Silva discovered that Hp0100
hydrolyzes ATP to ADP and Pi, and this ATP hydrolysis is enhanced in the presence of
either Asp-tRNAAsn or Glu-tRNAGln (Figure 1.10B) (87). Analysis of point mutations in the
two ATPase domains demonstrated that both ATPase sites are catalytically active and
AANH domain activity is specifically accelerated by Glu-tRNAGln, while the P-loop
responds to Asp-tRNAAsn (Figure 1.10C) (87). Hp0100 is the first example of an ATPase
with two different active sites that are activated by two different misacylated tRNAs.
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Figure 1.10. Hp0100 contains two distinct ATPase active sites, which are activated
by misacylated Asp-tRNAAsn and Glu-tRNAGln. (A) Hp0100 is an ATPase with an AANH
domain (magenta, residues 1-75) and a P-loop motif (blue, residue 76-84). A Rosetta
model of Hp0100 is shown with the AANH domain in magenta and the P-loop in blue. (B)
Hp0100 exhibits ATPase activity in the presence of misacylated tRNAs. An enzymecoupled assay was used to monitor ADP production via NADH oxidation to NAD+. (C)
Mutations in the AANH domain affect Hp0100’s Glu-tRNAGln-dependent ATPase activity
and its Asp-tRNAAsn-dependent ATPase activity is sensitive to mutants in the P-loop (87).
Figure provided by Dr. Gayathri Silva.
Further, sequence analysis and the predicted model structure suggest that Hp0100
also contains several, clustered, conserved cysteine residues, including a possible metal
binding motif with a CXXC signature sequence in the P-loop ATPase domain (Figure
1.11). Initial metal binding studies showed that Hp0100 preferentially binds divalent metal
ions such as Fe(II), Zn(II) and Ni(II).
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Figure 1.11. The putative metal-binding motif of Hp0100. Yellow: conserved Cysteine
residues in the CXXC motif. Red: Conserved Cysteine residues proximal to the CXXC
motif.
Chapter 4 of this dissertation focuses on cloning overexpression and purification
of Hp0100 protein constructs. Hp0100 difficult to reproducibly purify; consequently, we
turned to orthologs of this enzyme for further characterization. Full length Hp0100 is found
in -proteobacteria, however, truncated orthologs, composed of the N-terminal 2/3 of
Hp0100 are found in other bacterial clades. Chapter 5 will summarize our preliminary
characterization of a truncated Hp0100 ortholog from S. aureus, Sa2591.
1.9 Hp0100 and the truncated ortholog Sa2591 and queuosine biosynthesis
Queuosine is a modified guanosine base that is found in the first anticodon position
of tRNAAsp, tRNAAsn, tRNAHis, and tRNATyr (94-96). Even though queuosine is found in
both bacteria and eukaryotes, only bacteria are capable of biosynthesizing this modified
base; eukaryotes obtained it from their environment (94). The biosynthesis of queuosine
is a multistep process, where the first few steps occur on free guanosine triphosphate
(GTP), and the last three steps on the target tRNA (Figure 1.12). (97-98) After GTP is
converted into preQ1, transfer RNA-guanine transglycosylase (TGT) catalyze the transfer
of preQ1 onto its specific tRNA. PreQ1 is converted to epoxyqueuosine (oQ) by an S-
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adenosylmethionine ribosyltransferase-isomerase enzyme called QueA. The last step in
queuosine biosynthesis is the reduction of epoxyqueuosine to queuosine (Q) by a
cobalamine-dependent epoxyqueuosine reductase, QueG.
Some bacteria that biosynthesis queuosine contain TGT and QueA but lack QueG.
Recently, through comparative genomics, a group of proteins of unknown function
(DUF208) was identified as a putative epoxyqueuosine reductase. Both Hp0100 and
Sa2591 are DUF208 family members (Figure 1.12, last step). Overexpression of
Hp0100 and Sa2591 restored queuosine biosynthesis in a QueG E. coli strain (99),
indicating that these enzymes also have epoxyqueuosine reductase activity. We
hypothesize that these proteins have this activity when they not associated with the
transamidosome.
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Figure 1.12. The final three steps in queuosine biosynthesis. TGT catalyzes the
exchange of guanine 34 with preQ1 in target tRNAs. QueA catalyzes the conversion of
PreQ1 into epoxyqueuosine. This intermediate is then reduced to queuosine by QueG or
QueH. In organisms that lack QueG, the epoxyqueuosine reduction is catalyzed by
DUF208 family proteins, such as Hp0100 and Sa2591. These proteins have been
renamed QueH.
1.10 Dissertation research
This dissertation research is focused on broadening our understanding of bacterial
indirect tRNA aminoacylation pathways by characterization and elucidation of novel
activities of accessory proteins involved in this pathway. We hypothesize that accessory
proteins regulate transamidosome assembly in response to the environment. Under
favorable growth conditions, these proteins may promote stable assembly of the
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transamidosome and Asn-tRNAAsn and/or Gln-tRNAGln formation. But under unfavorable
conditions, they may detach from the transamidosome, leading to its disassembly and the
release of misacylated Asp-tRNAAsn and/or Glu-tRNAGln. These misacylated tRNAs
maybe incorporated into the proteome, providing conditions beneficial for the survival of
the organism.
Chapter 2 discusses the first isolation of an M. smegmatis transamidosome.
Chapter 3 focuses on the discovery of an unexpected enzymatic activity of bacterial
AspRSs. We demonstrate that some bacterial AspRSs are capable of acting as a GluRS
and produce Glu-tRNAGlu. Chapter 4 summarizes our efforts to clone, overexpress, and
purify Hp0100 without a His6-tag. In chapter 5, the preliminary characterization of a
truncated ortholog of Hpo100 called Sa2591 from S. aureus is presented.
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CHAPTER 2
M. SMEGMATIS TRANSAMIDOSOME ASSEMBLY
2.1 Introduction
In many organisms, a set of 20 aaRSs ensures the accurate aminoacylation of
tRNA and safeguards the fidelity of protein synthesis. However, many bacteria don’t have
a full set of aaRSs (15). In fact, most microorganisms lack AsnRS and/or GlnRS, and
consequently, rely on a two-step, indirect aminoacylation pathway to produce AsntRNAAsn and Gln-tRNAGln (34, 36-37, 43). This pathway proceeds via the misacylation of
tRNAAsn and tRNAGln to form Asp-tRNAAsn and Glu-tRNAGln, respectively. These reactions
are catalyzed by ND-AspRS and ND-GluRS (35, 43, 100). Next, a specific
amidotransferase, GatCAB in bacteria, converts these misacylated tRNAs into their
correctly aminoacylated forms (Asn-tRNAAsn and Gln-tRNAGln) (34, 37). The central hub
of the indirect tRNA aminoacylation pathway for Asn-tRNAAsn production is a
macromolecular complex called the Asn-transamidosome, which brings the misacylating
ND-AspRS and the correcting enzyme GatCAB together either via tRNA (77-78, 82, 101102) or another protein partner called Hp0100 (79). In comparison to the reported Asntransamidosomes (77-79, 82), to date, examples of analogous Gln-transamidosomes
(80-81) are less stable and more dynamic in nature and their physiological relevance
remains in doubt.
Evidence is accumulating that mistranslation is beneficial to organisms under
certain conditions, e.g. tolerance to antibiotics (76) and antifungals (103), amino acid
stress (104), oxidative stress (105-107), and growth temperature variations (108). The
Mycobacteria are the only organisms in which a clear connection between indirect tRNA
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aminoacylation and asparagine to aspartate mistranslation has been demonstrated (76).
M. tuberculosis (the pathogenic bacterium that causes tuberculosis) and M. smegmatis
(a benign, close relative of M. tuberculosis) lack genes encoding for either AsnRS or
GlnRS. Thus, they use the indirect tRNA aminoacylation pathway to produce both AsntRNAAsn and Gln-tRNAGln (47, 76). In particular, natural mutations in the GatA subunit of
GatCAB result in the mistranslation of aspartate at asparagine codons at low levels
throughout the Mycobacterial proteome (76). Remarkably, a particular mistranslation
event in RNA polymerase (RNAP) resulted in bacterial persistence and phenotypic
rifampicin tolerance (76). This work was described in more detail in section 1.7 of Chapter
1.
The mutants in GatCAB that induce mistranslation are located on the surface of
the GatA subunit rather than in the enzyme’s active site. We hypothesized that these
mutations may promote mistranslation by disrupting or destabilizing the Asntransamidosome. However, to date, wild-type Mycobacterial transamidosome(s) remain
uncharacterized. This chapter focuses on our efforts to isolate and characterize the M.
smegmatis transamidosomes, including the identification of two putative accessory
proteins that were co-purified with GatCAB by affinity chromatography.
2.2 Results
2.2.1 Several putative accessory proteins are co-purified with M. smegmatis
GatCAB constructs
We overexpressed and purified different combinations of the GatCAB subunits with
His6-tags as follows: GatB alone (His6-GatB); GatCA (GatA-His6 with co-expressed
GatC); and GatCAB (GatB-His6 with co-expressed GatCA) in the M. smegmatis mc2-155.
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Our aim was to characterize the Asn-transamidosome. However, upon purification under
mild conditions, we observed several proteins that repeatedly co-purified specifically in
the presence of GatA (Figure 2.1). Purification of GatB alone resulted in pure protein with
no evidence of endogenous GatA co-purification (Figure 2.1, panel A, lane 1). In
contrast, purification of GatCA resulted in co-purification of endogenous levels of GatB
with multiple other co-purified proteins. A similar pattern of co-purification was observed
when GatCAB was purified by Ni2+-affinity chromatography. Given that the H. pylori Asntransamidosome requires Hp0100 for assembly

(79) and the Mycobacteria lack an

Hp0100 ortholog, we hypothesized that these proteins might be important for Asntransamidosome assembly or function.
The two protein bands that were observed to co-purify with GatCA and GatCAB
were subjected to in-gel trypsin digestion and analyzed by mass spectrometry at the WSU
Proteomics Facility. These proteins were identified as MSMEG3950 (a universal stress
protein (USP), upper band) and superoxide dismutase (SOD, lower band).
Ten unique peptides from the in-gel trypsin digestion covered 44% of the protein
sequence of MSMEG3950 (Figure 2.1B). There are 14 USPs in M. smegmatis (47) and
the ortholog of MSMEG3950 from M. tuberculosis Rv2683 has being characterized (109110). Rv2683 is upregulated under hypoxic and nitrosative stress conditions. It is
proposed that Rv2683 is involved in bacterial persistence (110). Thirty unique peptides
were identified for SOD and covered 83% of the protein sequence (Figure 2.1C). The
role of SOD in protecting cells against oxidative damage is well characterized (111). Any
connection between MSMEG3950, SOD, and indirect tRNA aminoacylation is unknown
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and further experiments are needed to verify that these interactions are physiologically
relevant.

Figure 2.1. Putative accessory proteins co-purify with GatCAB. (A) SDS-PAGE gel
showing the co-purification of accessory proteins with different GatCAB constructs from
M. smegmatis. His6-GatB (lane 1), GatCA (GatA-His6 with co-expressed GatC, lane 2),
and GatCAB (GatB-His6 with co-expressed GatCA, lane 3). Proteins of unknown identity
that co-purified with GatA are labeled with asterisks. Red asterisks indicate those
characterized by mass spectroscopy. (B) Sequencing results of the top co-purified protein
band highlighted with a red asterisk in A. This band was identified as MSMEG3950. The
peptides highlighted in blue were observed by mass spectrometry. (C) The bottom band
was identified as superoxide dismutase by mass spectrometry. Observed peptides are
highlighted in blue.
2.2.2 Overexpression of GatCAB in M. smegmatis results in the co-purification of
ND-AspRS and ND-GluRS
We also examined purified GatCAB for the co-purification of endogenous NDAspRS or ND-GluRS as evidence of the formation of a stable transamidosomes. The
protein samples were purified in two ways: Co+2 affinity purification alone and Co+2 affinity
purification followed by size exclusion chromatography (SEC) (Figure 2.2). Neither NDAspRS nor ND-GluRS was visible in protein gels after purification of GatCAB indicated
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that they either did not co-purify or that co-purification occurred at levels too low to detect
by SDS-PAGE gel.

Figure 2.2. SDS-PAGE gel analysis of GatCAB purification. (A) SDS-PAGE gel
showing Co+2 affinity purification of overexpressed GatCAB from M. smegmatis. (B) SDSPAGE gel showing an additional SEC purification of GatCAB.
We turned to aminoacylation assays to more sensitively assess GatCAB for the
presence of co-purified ND-AspRS or ND-GluRS. As a control, we used an empty M.
smegmatis cell line (without overexpression of GatCAB). The assays from the protein
samples purified from Co+2 affinity chromatographic purification (Figure 2.2A, elution)
clearly indicated the co-purification of ND-AspRS and ND-GluRS with GatCAB (Figure
2.3). In these assays, the increase in the concentration of aa-tRNAaa indicates the
presence of the corresponding aaRS. There levels of ND-AspRS purification with GatCAB
are consistent with robust Asn-transamidosome formation (Figure 2.3A). These data
represent the first demonstration of a functional Mycobacterial Asn-transamidosome.
Compared to ND-AspRS, assay results suggested that ND-GluRS only weakly copurifies with GatCAB as part of a Gln-transamidosome (Figure 2.3B). These results are
consistent with other reports that have suggested that the Gln-transamidosome is notably
less stable than it’s Asn-transamidosome counterpart. Nevertheless, this observed
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activity suggested that we had isolated a Gln-transamidosome for the first time from any
bacterium. The empty M. smegmatis cell line was used as a control in both cases. The
expectation was that neither ND-AspRS nor ND-GluRS activity would be evident in these
assays following “purification” by Co2+-affinity. Surprisingly, considerable aminoacylation
activity was observed with this control in both cases suggesting that both aaRSs have
some nascent affinity for Co2+ resin.
Analogous enzyme assays were carried out using GatCAB that had been purified
by both Co+2 affinity and SEC in an effort to eliminate the challenges faced by the
unexpected ND-AspRS and ND-GluRS activity observed in the control samples (Figure
2.4). The data more robustly demonstrate that both ND-AspRS and ND-GluRS co-purify
with M. smegmatis GatCAB.

Figure 2.3. M. smegmatis ND-AspRS and ND-GluRS co-purify with the
overexpressed GatCAB in M. smegmatis cell line. (A) Aminoacylation assays with M.
smegmatis tRNAAsn and aspartate using the Co+2-affinity purified GatCAB confirm the copurification of ND-AspRS with GatCAB. (B) Aminoacylation assays with M. smegmatis
tRNAGln and glutamate using the Co+2-affinity purified GatCAB confirm the co-purification
of ND-GluRS with GatCAB. The empty Mycobacterial cell line was used as a control for
comparison. Error bars represent the standard deviation from biological triplicates.
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Figure 2.4. M. smegmatis ND-AspRS and ND-GluRS assemble into a
transamidosomes(s) with GatCAB. (A) Aminoacylation assays with M. smegmatis
tRNAAsn and aspartate with the Co+2 affinity followed by SEC purified GatCAB confirmed
the co-purification of ND-AspRS with GatCAB. (B) Aminoacylation assays with M.
smegmatis tRNAGln and glutamate with the Co+2 affinity followed by SEC purified GatCAB
confirmed the co-purification of ND-GluRS with GatCAB. Error bars represent the
standard deviation from biological triplicates.
2.2.3 The substrate specificity conundrum of M. smegmatis ND-AspRS
An important remaining conundrum in the field of indirect tRNA aminoacylation is
that we don’t understand how GatCAB can exist in an Asn-transamidosome and still
convert Glu-tRNAGln into Gln-tRNAGln. Some evidence suggests a Gln-transamidosome
(80-81), but the physiological relevance of these reports remain unclear. The formation
of a mega-transamidosome, composed of GatCAB, ND-AspRS, and ND-GluRS is difficult
to envision sterically. Consequently, the results presented in Figure 2.4, which suggest
that these three enzymes co-purify as a single complex, are particularly intriguing and
merited more detailed analyses.
To verify that the aminoacylation of tRNAAsn and tRNAGln is due to co-purified NDAspRS and ND-GluRS respectively, we performed aminoacylation assays with purified,
recombinant, M. smegmatis ND-AspRS and ND-GluRS for comparison (Figure 2.6). Both
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of these enzymes are expected to be non-discriminating, however, their precise tRNA
substrate specificities have never been reported. Consequently, our first step was to verify
that both of these enzymes were capable of aminoacylating their non-cognate tRNA
substrates: tRNAAsn for ND-AspRS and tRNAGln for ND-GluRS. These assays were
performed with the two M. smegmatis tRNAs, which had been overexpressed in E. coli
and purified as total tRNA. Consequently, these tRNAs are enriched for the specific M.
smegmatis isoacceptor of interest but they are contaminated with total E. coli tRNA.
As expected, M. smegmatis ND-GluRS is capable of producing Glu-tRNAGln, but
not Asp-tRNAAsn (Figure 2.5, dash lines), consistent with it being a canonical ND-GluRS.
Similarly, ND-AspRS aminoacylates tRNAAsn with aspartate (Figure 2.5A), consistent
with ND-AspRS activity. However, we were surprised to observe aminoacylation activity
with M. smegmatis ND-AspRS, tRNAGln, and glutamate (Figure 2.5B). This activity
indicates that M. smegmatis ND-AspRS is capable of producing Glu-tRNAGln or
aminoacylating a contaminating E. coli tRNA with glutamate (Figure 2.5B). In Chapter 3,
we further characterize this unexpected ND-AspRS activity and show that bacterial
AspRSs (both discriminating and non-discriminating) have the ability to produce GlutRNAGlu. Unfortunately, this unexpected ND-AspRS activity with glutamate raises
ambiguity with respect to the formation of an M. smegmatis Gln-transamidosome.
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Figure 2.5. M. smegmatis ND-AspRS aminoacylates at least one tRNA with
glutamate. (A) Aminoacylation of M. smegmatis tRNAAsn and/or E. coli tRNAs with
aspartate by M. smegmatis ND-AspRS versus ND-GluRS. (B) Aminoacylation of M.
smegmatis tRNAGln and/or E. coli tRNAs with glutamate by M. smegmatis ND-AspRS and
ND-GluRS.
2.2.4 ND-AspRS and GatCAB assemble into an Asn-transamidosome
We also evaluated the possibility of Asn and/or Gln-transamidosome formation by
native gel electrophoresis using overexpressed and purified ND-AspRS, ND-GluRS, and
GatCAB (Figure 2.6). A faint upward shift is observed when ND-AspRS is incubated with
increasing amounts of GatCAB (Figure 2.6, lanes 7, 9, and 10, indicated with an
asterisk), suggesting weak Asn-transamidosome formation. Repeated attempts to better
resolve this species, including the addition of tRNAAsn, were unsuccessful. No indication
of complex formation between ND-GluRS and GatCAB was observed (Figure 2.6, lane
5 and 8). These results could indicate a requirement for tRNA and/or an accessory
protein-like Hp0100 for robust transamidosomes assembly.
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Figure 2.6. Transamidosome evaluation by native gel electrophoresis. The formation
of Asn and/or Gln-transamidosome complexes was evaluated by native gel
electrophoresis and anti-His6 Western blots (ND-AspRS, ND-GluRS, and GatB were
modified with His6-tags). The upward shift of bands indicated by asterisks suggests
incomplete Asn-transamidosome assembly.
2.3 Discussion
M. smegmatis lacks genes for AsnRS and GlnRS, thus this bacterium requires
indirect tRNA aminoacylation for the production of Asn-tRNAAsn and Gln-tRNAGln. During
indirect tRNA biosynthesis, it is important to sequestrate the misacylated intermediates
Asp-tRNAAsn and Glu-tRNAGln from the ribosome until they are converted to Asn-tRNAAsn
and Gln-tRNAGln by GatCAB. One such mechanism is the formation of a macromolecular
complex called a transamidosome. The Asn-transamidosome bring together ND-AspRS
and GatCAB via either tRNAAsn (77-78, 82, 101-102) or an accessory protein-like Hp0100
(79). The reported Gln-transamidosomes also depend on tRNAGln but are more dynamic
and less stable than their Asn-transamidosome counterparts (80-81). How Glu-tRNAGln is
transferred from ND-GluRS to GatCAB remains an open question in the field.
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Here we have shown that purification of M. smegmatis GatCAB Co2+-affinity
purification and SEC results in the co-purification of endogenous ND-AspRS (Figure 2.3
and 2.4), clearly indicating Asn-transamidosome formation. This complex was also
assembled from its components and observe by native gel electrophoresis. Though
aminoacylation assays confirm the co-purification of ND-AspRS and GatCAB, they do not
provide details regarding the composition or the assembly of the transamidosome. Is the
transamidosome tRNA-dependent or does it require another protein partner analogous to
Hp100 for its assembly? These questions need to be addressed in the future.
Unfortunately, efforts to confirm co-purification of ND-GluRS with GatCAB were
less clear. Aminoacylation assays suggested that low levels of ND-GluRS did accompany
GatCAB through its purification; however, our discovery that M. smegmatis ND-AspRS
can produce Glu-tRNAGlu introduces uncertainty into these results. Acid gel
electrophoresis, combined with Northern blots, may prove useful to resolve this ambiguity.
For the time being, the possibility of a functional Gln-transamidosome remains
unresolved.
We have repeatedly observed several putative accessory proteins in our GatCAB
purifications (Figure 2.1) and have identified two of these proteins as a USP,
MSMEG3950, and SOD. These proteins were identified by in-gel trypsin digestion,
followed by sequencing of the peptide fragments by mass spectrometry. USP and SOD
are stress-related proteins (110-111). With the knowledge that mistranslation in M.
smegmatis results in persistence and phenotypic rifampicin tolerance (76), and that
mistranslation in other organisms can be beneficial under numerous stress-related
condition (76, 103-108), we speculate that these accessory proteins may disrupt or
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contribute to the M. smegmatis transamidosome. This hypothesis, while intriguing,
remains highly speculative at the present time. Additional experiments are needed to
further explore these putative interactions.
In conclusion, we have characterized the Mycobacterial transamidosome and have
identified two putative accessory proteins that may interact with the transamidosome,
both of which are relevant to stress. Future experiments need to be carried out to assess
the composition of the transamidosome under normal versus stress-inducing conditions.
2.4 Materials and Methods
2.4.1 Materials
Sodium dihydrogen phosphate (NaH2PO4), magnesium chloride, Tween-80, and
glucose were purchased from Sigma-Aldrich (St. Louis, MO). Ampicillin, kanamycin,
chloramphenicol, hygromycin B, ethylenediaminetetraacetic acid (EDTA), isopropyl -Dthiogalactopyranoside (IPTG), tris(hydroxymethyl) aminomethane (Tris), lysozyme, and
phenylmethanesulfonyl fluoride (PMSF) were from Gold Biotechnology, Inc. (St. Louis,
MO). Sodium chloride (NaCl) and glycine were purchased from Fisher Scientific
(Hampton, NH). Mouse anti-His6 tag antibody and goat anti-mouse IgG antibodies were
purchased from BIO-RAD (Hercules, CA).
2.4.2 Overexpression and purification of M. smegmatis GatCAB, GatB, and GatCA
M. smegmatis N-terminal His6-tagged GatB, C-terminus His6-tagged GatC with coexpressed GatA (GatCA), and C-terminal His6-tagged GatB co-expressed with GatCA
(GatCAB) were overexpressed in M. smegmatis mc2-155 using vectors kindly provided
by Dr. Babak Javid. The cultures were grown in Middlebrook 7H9 medium (0.8 L in a 4 L
flask) supplemented with glycerol (0.2%), Tween-80 (0.05%), hygromycin B (50 g/ml),
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and anhydrotetracycline (50 ng/mL) starting with a saturated culture grown in the same
medium supplemented with NaCl (0.85%), glucose (2%), and BSA (5%). The cultures
were incubated at 37 °C, 200 rpm until the OD600 reached between 1 and 2 (approximately
24-30 hours). The cells were harvested by centrifugation at 5,000 rpm for 15 min at 4 °C
and the cell pellets were kept at -80 °C until ready to use.
The His6-tagged GatB and GatCA proteins were only purified by Co2+ affinity
chromatography. The His6-tagged GatCAB was purified by Co2+-affinity and SEC. In all
three cases, for Co2+-affinity purification, the cell pellets were suspended in lysis buffer
(50 mM NaH2PO4 pH 7.4, 300 mM NaCl, 10 mM imidazole) and the cells were lysed with
lysozyme (2 mg/mL) and sonication. Saturated PMSF (15 L/mL) was added every 20
min to reduce proteolysis. The cell debris was separated from the lysate by centrifugation
at 14,000 rpm for 30 min at 4 °C. Typically, a cell extract was added to a polyprep column
that contained high-density cobalt agarose beads (~ 2 mL, Gold Biotechnology, Inc.) prewashed with lysis buffer. The lysate was incubated with the resin by rotating at 4 °C for 1
hour. The His6-tagged proteins were eluted according to the manufacturer’s protocol
(Gold Biotechnology). The proteins were dialyzed for one hour and then overnight in
dialysis buffer (50 mM NaH2PO4 pH 7.4, and 300 mM NaCl) and concentrated using 3
kDa molecular weight spin filters (EMD Millipore) prior to aminoacylation assays.
Immediately after Co2+-affinity purification and dialysis, the concentrated GatCAB
was injected onto a SEC column packed with Sephacryl S-300 high-resolution size
exclusion chromatographic resin (GE Healthcare Bio-Sciences, Uppsala, Sweden). The
proteins were eluted with SEC buffer (50 mM NaH2PO4 pH 7.4, and 300 mM NaCl) and
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fractions (5 mL) were collected and analyzed by SDS-PAGE. The fractions containing
pure GatCAB were combined and concentrated.
The empty M. smegmatis mc2-155 was grown in the above-mentioned culture
medium (without hygromycin B) and incubated at 37 °C, 200 rpm. The pellet was collected
and treated to the same purification protocol as GatCAB.
2.4.3 Overexpression and purification of M. smegmatis ND-AspRS and ND-GluRS
M. smegmatis ND-AspRS and ND-GluRS (vectors provided by Dr. Babak Javid),
were each overexpressed in E. coli Bl21(DE3)-RIL in Luria-Bertani medium (LB, 1 L)
supplemented with kanamycin (50 g/mL), chloramphenicol (100 g/mL), and glucose
(0.5%). The cultures were inoculated with a saturated overnight culture grown from a
single colony the same medium. The cultures were incubated at 37 °C, 200 rpm and
protein overexpression was induced at OD600 = 0.8-1 with IPTG (1 mM). The cells were
collected by centrifugation at 4,000 rpm for 10 min at 4 °C after 1-hour induction period.
The proteins were purified by Co2+-affinity as discussed above.
2.4.4 In vivo expression and purification of tRNAs
M. smegmatis tRNAAsn and tRNAGln (M. smegmatis vectors provided by Dr. Babak
Javid) were overexpressed, purified, and quantified as previously described (52, 73).
2.4.5 Aminoacylation assays with purified GatCAB
Aminoacylation assays were conducted in buffer containing 20 mM HEPES-OH,
pH 7.5, 4 mM MgCl2, 2 mM ATP, 100 M amino acid, and 50 Ci/mL 3H-labeled amino
acid. Assays were carried out using 10 M M. smegmatis tRNAAsn or tRNAGln as noted.
The Co2+-affinity purified GatCAB was added to a final concentration of 1 g/mL and 0.8
g/mL of GatCAB was used after the two-column purification. All assays were conducted
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in triplicate from different protein purifications. The same assays were carried out with
empty cell line purifications: in this case, the protein sample was concentrated to the same
volume as GatCAB and an equivalent volume was used.
2.4.6 Aminoacylation assays with purified recombinant M. smegmatis ND-AspRS
and ND-GluRS from E. coli
The extended (90 min) aminoacylation assays were conducted in buffer containing
20 mM HEPES-OH, pH 7.5, 4 mM MgCl2, 2 mM ATP, 200 M amino acid, and 25 Ci/mL
3H-labeled

amino acid. Assays were carried out using 10 M M. smegmatis tRNAAsn or

tRNAGln as noted. Purified recombined M. smegmatis ND-AspRS and ND-GluRS were
added to a final concentration of 1 M.
2.4.7 Mass spectrometric analysis of co-purified protein bands from M. smegmatis
GatCAB purification
The eluted GatCAB sample from Co2+-affinity purification was separated on a 12%
SDS-PAGE gel and visualized with Sypro Ruby stain (Molecular Probes, Eugene, OR).
The gel bands were excised, subjected to in-gel trypsin digestion, and analyzed by LCMS/MS at the WSU Proteomics Facility as previously described (112).
2.4.8 Transamidosome assembly analysis by electrophoretic mobility shift assays
Transamidosome formation between ND-AspRS (0.2 M), ND-GluRS (0.2 M),
and GatCAB (0.2, 0.4 and 0.8 M) was examined by native gel electrophoresis. The
protein samples were mixed as indicated and incubated at 4 °C for 30 min. The complexes
were separated on an 8% native PAGE in Tris-glycine buffer (25 mM Tris, 200 mM
glycine, pH 8.8). The gel bands were visualized by Western blot using anti-His6 antibodies
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(BIO-RAD, Hercules, CA). Both ND-AspRS and ND-GluRS contained C-terminal His6tags. GatCAB contained a C-terminus His6-tag on the GatB subunit.
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CHAPTER 3
BACTERIAL ASPARTYL-TRNA SYNTHETASE HAS GLUTAMYL-TRNA
SYNTHETASE ACTIVITY
The majority of this chapter is in press for publication in a special issue of Genes.
Rathnayake, U. M.; and Hendrickson, T. L. Bacterial Aspartyl-tRNA Synthetase Has
Glutamyl-tRNA Synthetase Activity. Genes 2019, 10, 262. DOI: 10.3390/genes10040262
Copyright © 2019, MDPI, reprinted with permission.
3.1 Introduction
The fidelity of protein translation depends on the accurate pairing of cognate
tRNAs to their cognate amino acids. The ligation of the amino acid to its tRNA is catalyzed
by a highly specific group of enzymes known as the aminoacyl-tRNA synthetases (aaRS)
(2, 11, 15). Under normal conditions, these enzymes maintain high accuracy and
specificity in selecting their cognate amino acid and tRNA substrates. In fact, decades of
research have been dedicated to demonstrating that the aaRSs are exquisitely specific
for their cognate substrates and are key players in defining the accuracy of the proteome
(15, 113-115). An increasing body of work, however, is emerging that demonstrates that
some aaRSs can alter their activity or relax their selectivity in response to stress, even
promoting errors in translation (4, 84, 116-119).
Aspartyl-tRNA synthetase (AspRS) is an exception to the rule of one aaRS per
amino acid/tRNA pair. It can be found in two general forms: discriminating and nondiscriminating, based on divergent tRNA specificities. Discriminating AspRS, the
canonical enzyme, is found in eukaryotes and some bacteria (e.g. Escherichia coli or E.
coli or Ec) and archaea, and catalyzes the aspartylation of tRNAAsp to produce AsptRNAAsp (Figure 3.1A) (16). The non-discriminating form, ND-AspRS, is found in many
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bacteria and archaea and some organelles; this enzyme cannot differentiate between
tRNAAsp and tRNAAsn and aminoacylates both with aspartate to generate Asp-tRNAAsp
and the misacylated Asp-tRNAAsn, respectively (Figure 3.1B) (31, 33, 35, 43). AsptRNAAsn is then converted to Asn-tRNAAsn by a glutamine-dependent amidotransferase
(AdT) (35-37, 43).

Figure 3.1. Canonical roles of AspRS and ND-AspRS. (A) AspRS aminoacylates
tRNAAsp with aspartic acid to produce Asp-tRNAAsp. (B) ND-AspRS catalyzes the
aspartylation of both tRNAAsp and tRNAAsn to produce Asp-tRNAAsp and the misacylated
Asp-tRNAAsn.
The requirement for a discriminating AspRS versus an ND-AspRS differs from
organism to organism; however, ND-AspRS is always accompanied by AdT (35-38). NDAspRS and AdT are typically found in organisms that lack asparaginyl-tRNA synthetase
(AsnRS) and/or asparagine synthetase (AsnS). Table 1.4, in chapter 1, lists examples of
such organisms and the gene distribution patterns of relevant genes. For example,
Pseudomonas aeruginosa (P. aeruginosa) and Helicobacter pylori (H. pylori or Hp) lack
both AsnRS and AsnS and consequently require ND-AspRS and AdT to produce both
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Asn-tRNAAsn and asparagine (49, 59). Mycobacterium tuberculosis lacks AsnRS but has
AsnS, so it only uses indirect tRNA aminoacylation to produce Asn-tRNAAsn (50). In
contrast, Staphylococcal aureus (S. aureus or Sa) has a functioning AsnRS but lacks
AsnS; thus, indirect aminoacylation is still required as the sole biosynthetic route to
asparagine (51). Some bacteria like Thermus thermophilus and Deinococcus radiodurans
encode for more than one copy of AspRS (45, 54).In these cases, the longer, bacterialtype AspRS is discriminating and catalyzes the synthesis of Asp-tRNAAsp. The second
AspRS (AspRS2) is non-discriminating and produces Asp-tRNAAsn along with AsptRNAAsp.
The relaxed specificity of archaeal and bacterial ND-AspRSs has been
characterized to some extent. The anticodon-binding domain of the archaeal-type and
bacterial-type AspRS are responsible for recognition of the anticodon bases of tRNA Asp
(AspRS and ND-AspRS) and tRNAAsn (ND-AspRS only). Many mutagenesis studies have
been conducted on this region of various AspRSs and ND-AspRSs from bacteria and
archaea to better understand how these enzymes recognize tRNAAsp and tRNAAsn. Table
3.1 summarizes the AspRS and ND-AspRS characterizations from different archaea and
bacteria reported so far. Figure 3.2 shows a sequence alignment of the anticodon-binding
domains of several bacteria and archaea and the crystal structure of E. coli AspRS with
tRNAAsp, highlighting the residues used in mutagenesis studies.
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Table 3.1. Summary of mutagenesis studies of AspRSs and ND-AspRSs anticodonbinding domains
Organism

Domain

D/ND1

Thermococcus
kodakaraenis

archaea

D

Deinococcus
radiodurans

bacteria

ND2

Pseudomonas
aeruginosa

bacteria

ND

Helicobacter
pylori

Bacteria

ND

Mutations3

Phenotype

• Converts D-AspRS to
• W26H
ND-AspRS
• K85P
• Increases specificity
• W26H/K85P
towards tRNAAsn
• Converts ND-AspRS to
• H28Q
D-AspRS
• P77K
• Reduces specificity
• H28Q/P77K
towards tRNAAsn
• Converts ND-AspRS to
• H31L
D-AspRS
• G83K
• Reduces specificity
• H31L/G83K
towards tRNAAsn
• Converts ND-AspRS to
• L81N
D-AspRS
• L86M
• Reduces specificity
• L81N/L86M
towards tRNAAsn

1

D is for discriminating AspRS and ND is for a nondiscriminating AspRS

2

Archaeal-type ND-AspRS

3 These

mutations are highlighted in Figure 3.2A

Ref.

(120)

(121)

(122)

(49)
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Figure 3.2. Anticodon-binding domains of the archaeal-type and bacterial-type
AspRSs. (A) Sequence alignment of anticodon-binding domains of different AspRS. The
secondary structure of H. pylori ND-AspRS is indicated above the alignment. The dashed,
grey line indicates the separation between archaeal-type and bacterial-type AspRSs. Tk:
T. kodakaraenis; Dr: D. radiodurans; Pa: P. aeruginosa; Hp: H. pylori; Ms: M. smegmatis;
Sa: S. aureus; and Ec: E. coli. Mutated residues in the P. aeruginosa study are in blue
(122) and those of the H. pylori study are in purple (49). The proline residue in the L1loop is marked in green. The mutated residues in archaeal-type AspRS are highlighted in
yellow (120-121). (B) The crystal structure of E. coli AspRS with tRNAAsp (PDB entry
1C0A). tRNAAsp is in black, the anticodon binding domain is in cyan, and the catalytic
domain is in magenta (123). (C) Close up of the anticodon-binding domain of E. coli
AspRS. The residues investigated by mutagenesis are represented in the same color as
in (A).
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While ND-AspRS clearly demonstrates relaxed tRNA substrate specificity, it
remains fine-tuned as it only aspartylates tRNAAsp and tRNAAsn, only in organisms that
have AdT, and it presumably discriminates against other tRNAs as potential substrates.
In this way, the fidelity of the genetic code is maintained. Evidence of further relaxation in
substrate specificity for either a discriminating AspRS or an ND-AspRS has not been
reported. In this chapter, we demonstrate that these enzymes are capable of specifically
producing Glu-tRNAGlu while maintaining their canonical roles: the production of AsptRNAAsp (AspRS and ND-AspRS) and Asp-tRNAAsn (ND-AspRS only). To the best of our
knowledge, this is the first example of an aaRS capable of producing a non-cognate, but
correctly aminoacylated, tRNA.
3.2 Results
3.2.1 H. pylori ND-AspRS appears to aminoacylate H. pylori tRNAGln with aspartate
and glutamate
ND-AspRS has relaxed tRNA specificity and aspartylates both tRNAAsp and
tRNAAsn to produce Asp-tRNAAsp and Asp-tRNAAsn, respectively (35, 43). We have
previously demonstrated that the Hp ND-AspRS has this dual tRNA specificity, as
expected (49). Given the nature of the genetic code and decades of work characterizing
the aaRSs, ND-AspRS should not demonstrate broader substrate specificity for noncognate tRNAs or amino acids. We examined Hp ND-AspRS and GluRS2, a tRNAGlnspecific GluRS (41-42), for possible cross-reactivity with overexpressed tRNAAsn and
tRNAGln with both aspartate and glutamate (Figure 3.3). We performed these assays with
longer time points to look at plateau levels of aminoacylation and to detect any low levels
of aminoacylation. As expected, ND-AspRS produced Asp-tRNAAsn and did not produce
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Glu-tRNAAsn (Figure 3.3, panels A, and B, respectively). Unexpectedly, this enzyme
showed aminoacylation activity in both assays with tRNAGln (Figure 3.3, panels C and
D), suggesting that it was producing the non-cognate product Hp Asp-tRNAGln and GlutRNAGln. However, because these tRNAs were overexpressed in vivo, a practice
necessary to introduce required post-transcriptional modifications like queuosine (124)
and 2-thiouridine (125), the tRNAs used in these experiments were contaminated with
total Ec tRNA. Thus, the possibility also exists that Hp ND-AspRS is aminoacylating one
or more Ec tRNAs instead. For comparison, GluRS2 showed only its expected activity,
producing Glu-tRNAGln (Figure 3.3, panel D), but not Asp-tRNAAsn, Glu-tRNAAsn, or AsptRNAGln (Figure 3.3, panels A-C). We conducted these same, longer aminoacylation
assays using the Ms ND-AspRS and ND-GluRS (Figure 3.4): we observed the same
behavior with glutamate, indicating that this phenomenon is found in bacteria beyond H.
pylori.
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Figure 3.3. Extended H. pylori tRNAAsn or tRNAGln aminoacylation assays with H.
pylori ND-AspRS and GluRS2 with aspartate versus glutamate. Hp ND-AspRS (●, 1
M) and GluRS2 (■, 1 M) were tested in cross-aminoacylation assays using Hp tRNAAsn
and tRNAGln with aspartate and glutamate. The indicated tRNA isoacceptor concentration
in each assay was 10 M; but each was contaminated with total Ec tRNA. (A) Hp tRNAAsn
aminoacylated with aspartate, (B) Hp tRNAAsn aminoacylated with glutamate, (C) Hp
tRNAGln aminoacylated with aspartate, and (D) Hp tRNAGln aminoacylated with glutamate.
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Figure 3.4. Extended M. smegmatis tRNAAsn or tRNAGln aminoacylation assays with
M. smegmatis ND-AspRS and ND-GluRS with aspartate versus glutamate. Ms NDAspRS (●, 1 M) and ND-GluRS (■, 1 M) were tested in cross-aminoacylation assays
using Ms tRNAAsn and tRNAGln with aspartate and glutamate. The indicated tRNA
isoacceptor concentration in each assay was 10 M; but each was contaminated with
total Ec tRNA. (A) Ms tRNAAsn aminoacylated with aspartate, (B) Ms tRNAAsn
aminoacylated with glutamate, (C) Ms tRNAGln aminoacylated with aspartate, and (D) Ms
tRNAGln aminoacylated with glutamate.
We repeated the assays shown in Figure 3.3 with shorter time points and lower
enzyme concentrations to look at initial rates (Figure 3.5). Under these more standard
conditions, the ability of ND-AspRS to ligate glutamate onto either Hp tRNAGln or a
contaminating Ec tRNA was masked (Figure 3.5D), offering an explanation for why this
activity has remained undiscovered. Robust aspartylation by Hp ND-AspRS, presumably
of contaminating Ec tRNAAsp and/or tRNAAsn, was observed, as anticipated (Figure 3.5C).
Our use of extended time point assays (Figure 3.3) revealed an unexpected
activity for ND-AspRS that was invisible under initial rate conditions (Figure 3.5). To our
knowledge, this is the first evidence of an ND-AspRS utilizing glutamate instead of

61

aspartate as its amino acid substrate. This activity makes some sense, however, given
the close structural similarities between aspartate and glutamate. Nevertheless, the
results presented in Figures 3.3, 3.4, and 3.5, still contained ambiguity with respect to
the identity of the relevant tRNA substrate since each tRNA was overexpressed and
purified with contaminating Ec tRNAs.

Figure 3.5. H. pylori ND-AspRS shows unexpected aminoacylation activity with
overexpressed H. pylori tRNAGln suggesting cross-reactivity with E. coli tRNA. Hp
ND-AspRS (●, 200 nM) and GluRS2 (■, 200 nM) were tested in cross-aminoacylation
assays using Hp tRNAAsn and tRNAGln with aspartate and glutamate. The indicated tRNA
isoacceptor concentration in each assay was 10 M; however, each tRNA was
contaminated with total Ec tRNA. (A) Hp tRNAAsn aminoacylated with aspartate, (B) Hp
tRNAAsn aminoacylated with glutamate, (C) Hp tRNAGln aminoacylated with aspartate, and
(D) Hp tRNAGln aminoacylated with glutamate. Error bars represent standard deviation
from biological replicates in triplicate.
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3.2.2 H. pylori ND-AspRS aminoacylates E. coli tRNAGlu with glutamate to produce
Glu-tRNAGlu
To more precisely examine the unexpected aminoacylation reaction(s) catalyzed
by Hp ND-AspRS, we turned to acid gel electrophoresis and Northern blotting techniques
(126). We continued to use Hp GluRS2 as a control because of its high specificity for GlutRNAGln production (41-42). The advantages of this approach are two-fold. First, the acidic
pH of these gels enables the separation of aminoacylated-tRNAs from their deacylated
counterparts, due to the extra charge provided by the protonated amino terminus of the
amino acid (126). Second, oligonucleotides can be designed for Northern blot
visualization that are specific for a desired tRNA isoacceptor. Thus, this approach allows
us to unequivocally identify the tRNA(s) being aminoacylated in a given experiment,
clearly resolving the ambiguity of the results presented above. Since Hp ND-AspRS uses
glutamate as a substrate (Figure 3.3), we hypothesized that it may be adding glutamate
onto Hp tRNAGln or Ec tRNAGlu. Consequently, we used this methodology to examine Hp
ND-AspRS-catalyzed aminoacylation of Hp tRNAGln and Ec tRNAGlu with aspartate versus
glutamate as its amino acid substrates. Northern blots were conducted with
overexpressed Hp tRNAGln contaminated with total Ec tRNA as a source of Ec tRNAGlu.
In both cases, oligonucleotides were designed to visualize only the tRNA of interest: Hp
tRNAGln and Ec tRNAGlu.
Hp ND-AspRS does not aminoacylate Hp tRNAGln with either aspartate or
glutamate (Figure 3.6, blot 1, lanes 2 and 3), suggesting that the activities observed
above (Figure 3.3C and D) are the result of aminoacylation of one or more Ec tRNAs.
(Compare to the production of Glu-tRNAGln by Hp GluRS2 in Figure 3.6, blot 1, lane 4.)
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In contrast, Hp ND-AspRS aminoacylates Ec tRNAGlu with glutamate to produce GlutRNAGlu (Figure 3.6, blot 2, lane 3), offering direct evidence that this ND-AspRS has noncanonical aminoacylation activity that goes beyond its ability to aspartylate tRNAAsp and
tRNAAsn. We considered the possibility that E. coli glutamyl-tRNA synthetase (Ec GluRS)
had inadvertently co-purified with Hp ND-AspRS, however, no evidence of this
contamination was observed by SDS-PAGE (Figure 3.7). Remarkably, Hp ND-AspRS
remains accurate, by pairing glutamate with tRNAGlu to produce correctly acylated GlutRNAGlu but not the misacylated Asp-tRNAGlu (Figure 3.6, blot 2, lanes 3 and 2
respectively). In other words, this enzyme is exhibiting activity consistent with a
canonical GluRS, in that it is ligating glutamate specifically to tRNAGlu.

Figure 3.6. H. pylori ND-AspRS aminoacylates E. coli tRNAGlu with glutamate
producing Glu-tRNAGlu. Hp tRNAGln, contaminated with total Ec tRNA, was
aminoacylated with either Hp ND-AspRS or GluRS2 with aspartate versus glutamate.
Aminoacylated versus deacylated tRNAs were separated in an acid gel. Specific tRNAs
and aminoacylated tRNAs were imaged using 32P-labeled oligonucleotides in the
Northern blots. The top panel was visualized with a Hp tRNAGln-specific primer and the
bottom panel used an Ec tRNAGlu-specific primer. Expected tRNA aminoacylation activity
is indicated with a black check mark (✓); unexpected aminoacylation activity is indicated
in red (✓); the absence of aminoacylation activity with a given tRNA is indicated with a no
symbol (⦸).
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Figure 3.7. SDS-PAGE of purified aaRSs. Each His6-tagged protein was purified to
near homogeneity by cobalt affinity followed by DEAE column purification. The
proteins were loaded onto an SDS-PAGE gel after this two-step purification. For clarity,
intermittent lanes were removed, as indicated by the white break between different lanes.
Each panel (A, B, and C) shows the results from a single gel. (A) SDS-PAGE analysis of
Hp GluRS2. (B) SDS-PAGE analysis of Hp ND-AspRS. (C) SDS-PAGE analysis of Ec
AspRS, GluRS, and ND-AspRS from Ms and Sa.
Next, we compared the initial rates and extents of glutamylation of total Ec tRNA
by Hp GluRS2, an enzyme that naturally uses glutamate as its substrate (41-42), and Hp
ND-AspRS, which unexpectedly also uses glutamate (Figure 3.8 and 3.9). Here, to
ensure that we could visualize this novel activity, we increased the concentration of each
enzyme when looking at aminoacylation of a non-cognate tRNA. We also verified that Ms
ND-AspRS has this ability to glutamylated total Ec tRNA (Figure 3.10). In these
experiments, the ability of ND-AspRS to produce Glu-tRNAGlu is clearly apparent.
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Figure 3.8. H. pylori ND-AspRS attaches glutamate to an E. coli tRNA. Hp ND-AspRS
was tested for its activity to aminoacylate Ec tRNA (50-100 M) with aspartate and
glutamate. Hp GluRS2 was also assayed for comparison. (A) Aminoacylation of Ec tRNA
with aspartate by Hp ND-AspRS (●, 100 nM) versus GluRS2 (■, 500 nM). (B)
Aminoacylation of Ec tRNA with glutamate by Hp ND-AspRS (●, 500 nM) versus GluRS2
(■, 100 nM). Error bars represent standard deviation from biological replicates in triplicate.

Figure 3.9. Extended total E. coli tRNA aminoacylation assays with H. pylori NDAspRS and GluRS2 with aspartate versus glutamate. Hp ND-AspRS (●, 1 M) was
tested for its activity with Ec tRNA (50-100 M) and aspartate versus glutamate. Hp
GluRS2 (■, 1 M) was also assayed for comparison. (A) Aminoacylation of Ec tRNA with
aspartate. (B) Aminoacylation of Ec tRNA with glutamate.
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Figure 3.10. Extended total E. coli tRNA aminoacylation assays with M. smegmatis
ND-AspRS and ND-GluRS with aspartate versus glutamate. Ms ND-AspRS (●, 1 M)
was tested for its activity with Ec tRNA (50-100 M) and aspartate versus glutamate. Ms
ND-GluRS (■, 1 M) was also assayed for comparison. (A) Aminoacylation of Ec tRNA
with aspartate. (B) Aminoacylation of Ec tRNA with glutamate.
3.2.3 Glu-tRNAGlu production is common among bacterial non-discriminating and
discriminating AspRSs
All experiments described so far with Hp and Ms ND-AspRS demonstrate that
these enzymes can attach glutamate to Ec tRNA and Hp ND-AspRS specifically produces
Ec Glu-tRNAGlu. Given that these are inter-species pairings in both cases, we decided
that it was important to examine the Ec discriminating AspRS for this activity with
homologous Ec tRNA. We also included the ND-AspRS from S. aureus to gain additional
perspective into the ubiquity of this unexpected activity. Acid gels and Northern blot
analyses using oligonucleotide probes that are specific for four different Ec tRNAs
(tRNAGlu, tRNAGln, tRNAAsp, and tRNAAsn) were conducted with all four enzymes: the
discriminating AspRS from E. coli and the ND-AspRSs from H. pylori, M. smegmatis, and
S. aureus (Figure 3.11). In many of the Northern blots shown below, the deacylated and
the aminoacylated tRNAs appear as two bands, presumably due to differences in posttranscriptional modifications of the tRNAs, as previously reported (42).
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Figure 3.11. Some bacterial AspRS’s aminoacylate E. coli tRNAGlu with glutamate
producing Glu-tRNAGlu. Northern blot analyses of total Ec tRNA aminoacylated with (A)
aspartate and (B) glutamate by Ec GluRS, Ec AspRS, Hp ND-AspRS, Ms ND-AspRS,
and Sa ND-AspRS. 32P-labeled oligonucleotides specific for Ec tRNAGlu, tRNAGln, tRNAAsp
and tRNAAsn were used for each blot as indicated. Expected tRNA aminoacylation
activities are indicated with a black check mark (✓); unexpected activities are indicated in
red (✓); the absence of aminoacylation activity with a given tRNA is indicated with a no
symbol (⦸).
Figure 3.11 shows the Northern blot results obtained from total Ec tRNA
aminoacylated with aspartate (A) and glutamate (B) by different bacterial aaRSs: Ec
GluRS was used as a control. The results of panel A reveal that each AspRS attaches
aspartate to tRNAAsp and the three ND-AspRSs also attach aspartate to tRNAAsn, as
expected (Figure 3.11A, blots 3 and 4). Furthermore, none of the enzymes tested were
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capable of attaching significant amounts of aspartate to either non-cognate tRNA
substrates tRNAGlu or tRNAGln (Figure 3.11A, blots 1 and 2).
The most interesting and critical results are revealed in blot 1 in Figure 5B and
are highlighted with red checkmarks. This blot was probed with a

32P-labeled

oligonucleotide specific for Ec tRNAGlu; Glu-tRNAGlu formation by Ec GluRS was used as
a positive control. A clear shift is observed between deacylated tRNAGlu and Glu-tRNAGlu
produced by Ec GluRS (Figure 3.11B, blot 1, lanes 1 and 2). What is remarkable is that
all four AspRSs showed this same shift, clearly indicative of ubiquitous Glu-tRNAGlu
production. The remaining blots in Figure 3.11B demonstrate that this glutamylation
activity is specific for tRNAGlu as none of the enzymes tested were capable of adding Glu
onto Ec tRNAGln, tRNAAsp, or tRNAAsn. These data demonstrate that Ec AspRS and the
three ND-AspRSs tested all aminoacylate tRNAGlu with glutamate to produce GlutRNAGlu. These reactions represent a new, non-canonical activity for AspRS that can be
viewed as that of a discriminating GluRS.
3.3 Discussion
In this work, we demonstrate that bacterial discriminating and non-discriminating
AspRSs have quantifiable GluRS activity as they are capable of specifically generating
Glu-tRNAGlu. Using total Ec tRNA, this activity was observed with four different AspRSs:
the Ec discriminating AspRS and three non-discriminating AspRSs from H. pylori, M.
smegmatis, and S. aureus. All four enzymes have canonical AspRS activity and produce
Asp-tRNAAsp (Figure 3.11A, blot 3). The three ND-AspRSs also produce misacylated
Asp-tRNAAsn (Figure 3.11A, blot 4); this intermediate would be converted to Asn-tRNAAsn
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in vivo by AdT. All four enzymes were also capable of specifically producing Glu-tRNAGlu
(Figure 3.11B, blot 1) without adding glutamate to other related tRNAs.
We considered the possibility of the co-purification of contaminating Ec GluRS as
an alternative explanation for this activity. However, each AspRS was purified in two
steps: cobalt affinity and DEAE chromatography. Ec GluRS elutes from our DEAE column
at a lower KH2PO4 concentration (~50-100 mM) than the tested AspRSs (~200-300 mM),
such that any GluRS that survived the affinity purification step would have been removed
by DEAE chromatography. Furthermore, no evidence of GluRS contamination was visible
by SDS-PAGE gel (Figure 3.7). Thus, this two-step purification strategy eliminates the
possibility of contaminated Ec GluRS in the AspRS samples confirming that this activity
is due to AspRS alone.
This GluRS-like activity of AspRSs is remarkable and unexpected because it is
accurate and yet outside the normal purview of an AspRS. It truly is GluRS activity as
each AspRS specifically attaches glutamate only to tRNAGlu producing Glu-tRNAGlu. The
fact that Ec AspRS demonstrates this activity is particularly important because of the
homologous nature of this result: Ec AspRS produces Ec Glu-tRNAGlu. All other results
herein arose from heterologous pairings of an AspRS with Ec tRNA. Our results with Ec
AspRS demonstrate that this activity is not simply a result of cross-species recognition of
a non-cognate tRNA. It is also remarkable that no evidence of misacylated Asp-tRNAGlu,
Glu-tRNAAsp, or Glu-tRNAAsn was observed, given the ability of these AspRSs to produce
Glu-tRNAGlu. This observation is important because it demonstrates that this GluRS
activity does not threaten the fidelity of the genetic code. Nevertheless, it poses an
unexpected problem with molecular recognition: How does AspRS know to specifically
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attach Asp to tRNAAsp (and tRNAAsn) and Glu to tRNAGlu without cross misacylation of
these tRNAs? Our results suggest that communication between the amino acid and tRNA
binding sites must occur to achieve this specificity. Further research is needed to
understand this apparent tRNA-induced conformational change.
AaRSs almost always recognize discrete molecular features in their tRNA
substrates, termed identity elements. These determinants can be positive and favor
recognition or negative and disfavor interactions. Figure 3.12 shows the identity elements
of E. coli tRNAAsp and tRNAGlu. For Ec tRNAAsp, the GUC anticodon, the G73 discriminator
base, the G2:C71 base pair in the acceptor stem, C38 in the anticodon loop, and G10 in
the D arm serve as the positive identity elements for Ec AspRS (25, 127-128). In contrast,
Ec GluRS recognizes the G1:C72 and U2:A71 base pairs in the acceptor stem, A37 in
the anticodon loop, U11:A24 base pair in D arm, and the U13:G22-A46 tertiary base pair
in Ec tRNAGlu. Further, the lack of a nucleotide at position 47 and the modified uridine
(s2U) in the UUC anticodon of tRNAGlu are also known identity determinants (25, 27, 125,
129-130). Ec tRNAGlu does contain several tRNAAsp identity elements: the G73
discriminator base, G10 in the D arm, and C38 in the anticodon loop. But are these shared
elements enough for recognition of Ec tRNAGlu by Ec AspRS? Or is an alternative,
expanded identity set recognized in such a way as to favor glutamylation of Ec tRNAGlu.
To answer these questions, the identity elements in Ec tRNAGlu that allow recognition by
Ec AspRS would have to be specifically evaluated.
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Figure 3.12. Sequence and secondary structure of E. coli tRNAs. (A) Ec tRNAAsp and
(B) Ec tRNAGlu. The major identity elements are highlighted by filled circles in red
(anticodon) and in black (other regions). The tRNAAsp identity elements that are found in
tRNAGlu are circled in black.
In conclusion, we have demonstrated that bacterial AspRSs have modest,
background GluRS activity and are capable of producing Glu-tRNAGlu, at least in vitro.
The relevance of this reaction in vivo is very difficult to demonstrate as it is unlikely that
this activity is robust enough to enable deletion of the native Ec GluRS, especially in the
presence of the cognate tRNAAsp substrate. It is possible that this activity exists as a
backup in case the cognate GluRS becomes damaged, for example. It is also possible
that it is a remnant of early AspRS evolution. The early genetic code was likely sloppy
with ancestral aaRSs capable of aminoacylating multiple tRNAs with different amino acids
(114). Evidence also suggests that Class I and II enzymes emerged in pairs (12, 131),
with early AspRSs and GluRSs perhaps as a co-evolving pair that recognized and
acylated the same early tRNA or tRNA-like substrates These enzymes would have
recognized opposite faces of the tRNA, facilitating this co-evolution and protecting the
tRNA from hydrolysis (12). Given that the background GluRS activity exhibited by AspRS
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doesn’t put the genetic code in jeopardy, it wouldn’t have been selected against as the
genetic code evolved to be more selective and specific. The results presented here also
suggest the possibility that other aaRSs retain similar background activities, a hypothesis
that awaits further testing.
3.4 Materials and Methods
3.4.1 Materials
Potassium dihydrogen phosphate (KH2PO4), sodium dihydrogen phosphate
(NaH2PO4), L-aspartic acid (catalog #A93100, batch #12002LC), L-glutamic acid (catalog
#G1251, lot #SLBK8671V), magnesium chloride, and oligonucleotides were purchased
from Sigma-Aldrich (St. Louis, MO). The radiolabeled reagents aspartic acid, L-[2,3-3H]
(catalog #ART 0211, lot #180606), glutamic acid, L-[2,3,4-3H] (catalog #ART 0132, lot
#180710) and adenosine triphosphate (ATP) [-32P] were purchased from American
Radiolabeled Chemicals (St. Louis, MO). Ampicillin, chloramphenicol, kanamycin, 4-(2hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), ethylenediaminetetraacetic acid
(EDTA), isopropyl--D-thiogalactopyranoside (IPTG), phenylmethanesulfonyl fluoride
(PMSF), and tris(hydroxymethyl) aminomethane (Tris) were from GoldBio Biotechnology,
Inc. (St. Louis, MO). Potassium chloride (KCl), sodium chloride (NaCl), and ammonium
acetate (NH4OAc) were purchased from Fisher Scientific (Hampton, NH).
3.4.2 Overexpression and purification of aaRSs
Hp ND-AspRS (49), the Hp tRNAGln-specific glutamyl-tRNA synthetase (GluRS2)
(42), Ms ND-AspRS, Ms ND-GluRS (Ms vectors provided by Dr. Babak Javid), and Ec
AspRS and Ec GluRS (Ec vectors provided by Dr. Takuya Ueda (132)) were each
overexpressed in E. coli Bl21(DE3)-RIL in Luria-Bertani medium (LB, 1 L) inoculated with
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a saturated overnight culture grown from a single colony. The cultures were incubated at
37 °C, 200 rpm. IPTG (1 mM) was used to induce overexpression in each case. For Hp
ND-AspRS and GluRS2 overexpression, the medium was supplemented with ampicillin
(100 g/mL), chloramphenicol (100 g/mL), and glucose (0.5%). IPTG was added when
the OD600 reached 0.8-1.0. Cells were collected after a 1-hour induction period. For Ms
ND-AspRS and ND-GluRS, the only difference was that kanamycin (25 g/mL) was
added instead of ampicillin. The two discriminating E. coli enzymes were grown in the
same medium as the two H. pylori enzymes. IPTG induction was initiated when the OD600
reached between 0.4 and 0.6 and continued for 4 hours. Cells were harvested by
centrifugation and frozen at -80 °C until ready for use.
The Sa ND-AspRS (vector provided by Dr. Kelly Sheppard) was overexpressed
and purified as previously described (51). In all other cases, cell pellets were suspended
in lysis buffer (50 mM NaH2PO4 pH 7.4, 300 mM NaCl, 10 mM imidazole) and the cells
were lysed with lysozyme (2 mg/mL) and sonication. Saturated PMSF (15 L/mL) was
added every 20 min to reduce proteolysis. Typically, a cell extract was added to a
polyprep column that contained high-density cobalt agarose beads (~2 mL, Gold
Biotechnology, Inc.) pre-washed with lysis buffer. The lysate was incubated with the resin
by rotating at 4 °C for 1 hour. The His6-tagged aaRSs were eluted according to the
manufacturer’s protocol (Gold Biotechnology).
The eluents were dialyzed against dialysis buffer (20 mM KH2PO4 pH 7.2, 0.5 mM
Na2EDTA, 5 mM -mercaptoethanol) at 4 °C for 1-2 hour and then against fresh dialysis
buffer overnight. The aaRSs were adsorbed onto a HiTrap TM DEAE FF column (GE
Healthcare Life Sciences). The proteins were eluted with a stepwise gradient of 20-300
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mM KH2PO4, pH 7.2, supplemented with 0.5 mM Na2EDTA, 5 mM -mercaptoethanol.
The proteins were concentrated with 30 kDa molecular weight spin filters (EMD Millipore).
After this two-column purification procedure, all enzymes were judged to be >99% pure
by SDS-PAGE. Final protein concentrations were determined by UV-Vis spectroscopy at
280 nm, using extinction coefficients calculated using the ExPASy ProtParam tool (133).
The aaRSs were immediately used in aminoacylation assays.
3.4.3 In vivo transcription and purification of tRNAs
Hp tRNAAsn (49), Hp tRNAGln (42), Ms tRNAAsn, and Ms tRNAGln (Ms vectors
provided by Dr. Babak Javid) were overexpressed in E. coli MV1184 and purified as
previously described (73). After deacylation, the tRNAs were electroeluted in a denaturing
urea gel for further purification. The tRNA band was excised from the gel, crushed, and
incubated overnight at 37 °C in crush and soak buffer (0.5 mM NH4OAc pH 5.2, 1 mM
Na2EDTA). The eluted tRNA sample was isopropanol precipitated. The resultant pellet
was dissolved in water, folded and quantified by aminoacylation assay as previously
described (73). These purifications yield tRNA that is enriched with the overexpressed
tRNA isoacceptor but also contains total Ec tRNA. Separately, total Ec tRNA was isolated
from a saturated E. coli MV1184 culture that had been grown at 37 °C in LB medium
supplemented with glucose (0.5%) and purified as described (73). The concentration of
total tRNA was calculated by UV-Vis spectroscopy at 260 nm assuming 1 OD = 1.6 M.
3.4.4 Initial rate aminoacylation assays
Each tRNA was pre-folded as previously described (73). Aminoacylation assays
were conducted in buffer containing 100 mM Na-HEPES, pH 7.5, 30 mM KCl, 12 mM
MgCl2, 2 mM ATP, 0.1 mg/mL BSA, 20 M amino acid, 50 Ci/mL 3H-labeled amino acid,
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and 10 M Hp tRNAAsn or tRNAGln as noted. Assays were conducted at 37 °C and were
initiated with the addition of 200 nM Hp ND-AspRS or GluRS2. Aliquots were removed
and quenched on Whatman filter pads containing trichloroacetic acid (TCA). The pads
were washed 3 times for 15 min with chilled 5% TCA. Pads were dried and counted in 3
mL ECOLITE(+) scintillation fluid (MP Biomedicals). Aminoacylation assays with total Ec
tRNA were carried out in the same buffer containing 50 to 100 M total tRNA. Hp NDAspRS (100 nM or 500 nM) or Hp GluRS2 (100 nM or 500 nM) were used in these assays
as noted. All experiments were conducted using biological replicates in triplicate.
3.4.5 Extended aminoacylation assays (90 min) by aaRSs
All the aaRSs used in these assays were only purified by cobalt affinity purification.
The aminoacylation assays were conducted in buffer containing 20 mM HEPES-OH, pH
7.5, 4 mM MgCl2, 2 mM ATP, 100 M amino acid, and 25 Ci/mL 3H-labeled amino acid.
All aaRSs were added to a final concentration of 1 M. Overexpressed tRNA isoacceptor
(10 M) or total E. coli tRNA (50 – 100 M) were included as indicated.
3.4.6 Acid gel electrophoresis and Northern blot analysis
Aminoacylation reactions were conducted as described above only without
radiolabeled amino acid for 90 min at 37 °C with 500 nM aaRS. NaOAc (0.3 mM, pH 4.5)
was added to each reaction and they were quenched with phenol/chloroform (1:1 v/v, pH
4.5). The tRNAs were ethanol precipitated and the resultant pellets were dissolved in
buffer containing 10 mM NaOAc, pH 4.5, 1 mM Na2EDTA. Acid gel electrophoresis was
used to separate deacylated tRNAs from their aminoacylated counterparts. The tRNA
samples were quantified by UV-Vis spectroscopy at 260 nm and 0.05 OD260 units were
loaded per lane for overexpressed tRNAs. This amount was increased to 0.25 OD 260 units
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for total Ec tRNA. Isoacceptor-specific oligonucleotides were used in Northern blots to
visualize each tRNA (Table 3.2). The tRNA specific DNA probes were prepared as
previously described (42). The acid gel and Northern blot analyses were performed as
previously described (42, 126), with the exception that a non-specific DNA oligonucleotide
(0.1 M) was added during the first three washing steps after probe hybridization.
Table 3.2. The tRNA specific oligonucleotide sequences used in Northern blot
analyses
tRNA
H. pylori tRNA

Sequence
Gln

CTCGGAATGCCAGGACCAA

E. coli tRNA

Glu

E. coli tRNA

Gln(UUG)

E. coli tRNA

Asp

CCGCGACCCCCTGCGTGACA

E. coli tRNA

Asn

CAGTGACATACGGATTAACA

CCCTGTTACCGCCGTGAAA
CAGGGAATGCCGGTATCAAA
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CHAPTER 4
CLONING, OVEREXPRESSION, AND PURIFICATION OPTIMIZATION STRATEGIES
FOR HP0100, A PROTEIN INVOLVED IN INDIRECT TRNA AMINOACYLATION
4.1 Introduction
H. pylori and other organisms that do not have either AsnRS and/or GlnRS utilize
an indirect tRNA aminoacylation pathway to produce Asn-tRNAAsn and/or Gln-tRNAGln (11,
15, 31-32, 34, 37, 42). The first step for Asn-tRNAAsn synthesis involves misacylation of
tRNAAsn with aspartate to produce Asp-tRNAAsn by ND-AspRS (35, 43). Subsequently, an
amidotransferase called GatCAB converts Asp-tRNAAsn to Asn-tRNAAsn (34, 37, 44-45).
An analogous, two-step processes exists to produce Gln-tRNAGln. In this case, ND-GluRS
or GluRS2 in H. pylori misacylates tRNAGln to produce Glu-tRNAGln (40-42), which is then
converted to Gln-tRNAGln by GatCAB (34, 36, 38). (This pathway is discussed in detail in
chapter 1, section 1.3.) Mechanism/s for the quick delivery of misacylated-tRNAs, either
from ND-AspRS or ND-GluRS/GluRS2 to GatCAB must exist to ensure the fidelity of
protein synthesis. For example, T. thermophilus assembles a stable ribonucleoprotein
complex called the Asn-transamidosome from tRNAAsn, GatCAB, and ND-AspRS. This
complex protects the aminoacyl ester linkage in Asp-tRNAAsn, sequesters Asp-tRNAAsn
from the ribosome until it is converted to Asn-tRNAAsn by AdT, and ensures efficient
production of Asn-tRNAAsn (77, 82).
Efforts to characterize an H. pylori Asn-transamidosome, composed of tRNAAsn,
ND-AspRS, and GatCAB were unsuccessful (80, 83). However, data-mining of a
published Y2H interaction profile of the H. pylori proteome led our lab to discover a protein
called Hp0100, which shows interactions with both proteins (ND-AspRS and GatCAB)
involved in Asn-tRNAAsn biosynthesis (79, 86).
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Dr. Gayathri Silva demonstrated that Hp0100 is an essential component of a tRNAindependent Asn-transamidosome in H. pylori

(79, 87). In the proposed Asn-

transamidosome, first, Hp0100 brings ND-AspRS and GatCAB together to form a stable
apo-transamidosome. This complex then binds tRNAAsn to form a holo-transamidosome
and ND-AspRS aspartylate tRNAAsn to form Asp-tRNAAsn. Next, CatCAB transamidates
the misacylated Asp-tRNA to Asn-tRNAAsn and the correctly aminoacylated product is
released, regenerating the apo-transamidosome (Chapter 1, Figure 1.8) (79). Further,
Dr. Silva demonstrated that Hp0100 accelerates the GatCAB catalyzed transamidation of
Asp-tRNAAsn into Asn-tRNAAsn ~35-fold (2) and Glu-tRNAGln into Gln-tRNAGln ~ 3-fold (87)
(Chapter 1, Figure 1.9).
A conserved domain analysis of Hp0100 identified two putative ATPase domains;
an AANH domain and a P-loop motif (88). Hp0100 hydrolyzes ATP to ADP and Pi, and
mutational studies demonstrated that these two active sites each respond to a different
misacylated tRNAs. The AANH domain enhances its activity in the presence of GlutRNAGln and the P-loop is stimulated with Asp-tRNAAsn (Chapter 1, Figure 1.10) (87).
Further, sequence analysis of Hp0100 revealed a possible metal binding motif with
a CXXC signature sequence in the P-loop ATPase domain. The predicted model structure
also displayed several other cysteines that are clustered together with this possible metal
binding cysteines (Chapter 1, Figure 1.11) (87). Preliminary metal binding studies by Dr.
Gayathri Silva showed that Hp0100 preferentially binds divalent metal ions such as Fe(II),
Zn(II) and Ni(II).
The Hp0100 plasmid construct (pTC034), that was used by Dr. Gayathri Silva,
encodes an N-terminal six-histidine tag. Several challenges arose when working with
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Hp0100 from this plasmid. First, given that His6-tags can bind metal ions, we were
concerned that results obtained with His6-Hp0100 would be difficult to interpret,
particularly with respect to any efforts to characterize its metal-binding sites. Second,
purification of His6-Hp0100 results in the co-purification of E. coli AspRS (87). Third, this
construct did not always lead to successful purifications of His6-Hp0100, due to solubility
challenges with this protein. To address all of these issues, we set out to evaluate better
ways to overexpress Hp0100 to homogeneity. Many different strategies were assessed,
none of which proved to be robustly effective. Representative examples of these
purification attempts are discussed here.
4.2 Results
Table 4.1 summarizes the different plasmids of Hp0100 that were constructed and
examined here. Efforts to purify Hp0100 using each of these different plasmids will be
separately discussed.
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Table 4.1. Plasmids encoding different variations of Hp0100
Plasmid

Parent
plasmid

pUD002

pGS024 Removal of the His6 tag

pUD003

pUD007

pUD009

pUD010

pUD011

pUD012

Description

Site-directed
mutagenesis to convert
pUD002
S84A mutant back to
wild type
Appendage of an Nterminal glutathione SpGEXtransferase (GST) tag
4T3
followed by a thrombin
cleavage site
Insertion of a tobacco
etch virus (TEV)
protease cleavage
pTC034
sequence between the
His6 tag and the
hp0100 gene
Codon-optimized
hp0100 gene with an
pQEN-terminal TEV site
80L
(GenScript) was cloned
into the pQE-80L
vector
Cloned wild type
hp0100 gene into the
2S-T
2S-T vector (Addgene)
to add a cleavable Nterminal Sumo tag
Cloned codonoptimized hp0100 gene
into the 2S-T vector
2S-T
(Addgene) to add a
cleavable N-terminal
Sumo tag

Illustration
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4.2.1 Cloning, overexpression and purification of untagged Hp0100
To remove the N-terminal His6-tag from wild type (WT) and mutant Hp0100
containing plasmids, the plasmids were digested with EcoRI and BamHI restriction
endonucleases, as these sites two flanks codons of the His6-tag. After digestion, primers
lacking the His6-coding sequence (UD005 and UD006) were dropped in between the
EcoRI and BamHI sites. The resulting plasmid encodes the untagged Hp0100. This
approach was first successful using pGS024, a plasmid from Dr. Silva, that encodes the
S84A Hp0100 mutant. The mutant hp0100 gene in the resulting plasmid, pUD002, was
reverted to WT by site-directed mutagenesis to obtain plasmid pUD003.
Using pUD003, we set out to optimize the overexpression and purification of WT
Hp0100 without a tag. Growth and overexpression conditions were varied in DH5 and
BL21(DE3)-RIL cell lines by examining expression at different growth temperatures,
induction times, and IPTG concentrations. Most of the tested conditions resulted in
minimal soluble overexpression of Hp0100 protein compared to uninduced controls
(results not shown). However, overexpression in DH5 at 19 °C with 1 mM IPTG induction
at OD600 for 16-18 hours resulted in considerable solubilized protein and therefore was
used in the optimization of purification protocols.
With the removal of the His6-tag from the plasmid, a new purification protocol had
to be developed. Figure 4.1 shows a representative example of these efforts to purify
untagged WT Hp0100 protein. Hp0100 was partially purified by ammonium sulfate
precipitation (Figure 4.1A). Cation exchange chromatography produced moderately pure
Hp0100 (Figure 4.1B) however yields were low and not robustly reproducible. Based on
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these results, we chose to examine the applicability of other affinity tags on the purification
of Hp0100.

Figure 4.1. Purification optimization of untagged Hp0100 protein. (A) SDS-PAGE
analysis of ammonium sulfate precipitation. The protein is soluble in lysis buffer and
precipitated with 50% ammonium sulfate. Each lane represents different loading volumes.
(B) SDS-PAGE analysis of cation exchange chromatographic elution fractions. Untagged
Hp0100 elutes with 300-350 mM NaCl concentration.
4.2.2 Cloning, and overexpression of GST-Thrombin-Hp0100
The WT hp0100 gene from pUD003 was cloned into the pGEX-4T3 expression
vector using BamHI and XmaI restriction site, resulting in an N-terminal GST tag followed
by a thrombin cleavage sequence (pUD007). This plasmid construct allows for protein
purification by glutathione affinity followed by cleavage of the GST tag using thrombin.
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Hp0100 was overexpressed from pUD007 in E. coli BL21(DE3)-RIL. Protein
overexpression was carried out at two different temperatures, 19 °C and 37 °C, with
different IPTG concentrations and expression times. GST-thrombin-Hp0100 could be
overexpressed under these conditions however the protein was insoluble and was only
observed in the pellet fraction (Figure 4.2).

Figure 4.2. SDS-PAGE analysis of the overexpression of GST-thrombin-Hp0100 in
E. coli BL21(DE3)-RIL. Overnight induction with 1 mM IPTG at 0.4-0.6 OD600 at 19 °C
(1) and 4-hour induction with 1 mM IPTG at 0.4-0.6 OD600 at 37 °C (2). Un: uninduced;
In: Induced; P: pellet; L: lysate.
4.2.3 Cloning, overexpression and purification of His6-TEV-Hp0100
A TEV protease cleavage site was inserted into pTC034 between the His6 codons
and the Hp0100 open reading frame to facilitate removal of the His 6-tag after affinity
purification. To this end, the plasmid was digested with BamHI and DNA oligonucleotides
containing the TEV protease recognition sequence (UD015 and UD016) were inserted
into the digested plasmid (pUD009). We also purchased a codon-optimized hp0100 gene
with a 5’-TEV protease cleavage sequence for expression from GenScript. This codon
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optimized hp0100 gene sub-cloned into the pQE-80L expression vector using BamHI and
SalI sites to incorporate an N-terminal polyhistidine tag (pUD010).
Overexpression conditions for the WT and codon-optimized His6-TEV-Hp0100
constructs were tested under different conditions. Under a variety of different conditions,
both clones resulted in visible overexpression and the majority of the protein was in the
soluble fractions as desired. Figure 4.3 shows representative results with the codonoptimized gene.
We chose to purify codon-optimized His6-TEV-Hp0100 from a DH5 culture grown
at 19 °C with 1 mM IPTG induction for 16 hours. The strategy was to purify this protein
by Ni+2-affinity (Figure 4.4A) and cation exchange chromatography (Figure 4.4B),
followed by cleavage of the N-terminal His6-tag using TEV protease (Figure 4.4C).
Unfortunately, Hp0100 was only modestly purified by Ni+2-affinity purification. Although
the cation exchange chromatography resulted in further purification (Figure 4.4B), the
major issue with this purification was failure in the TEV protease cleavage reaction
(Figure 4.4C). Different lysis methods and TEV protease cleavage conditions were
tested, but none proved to be successful.
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Figure 4.3. SDS-PAGE analysis of the overexpression of His6-TEV-codon optimized
Hp0100 (pUD010) in E. coli DH5. (A) Overexpression analysis at 37 °C. (B)
Overexpression analysis at 19 °C. Each lane was loaded with 10 g of total protein. P:
pellet. L: lysate.
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Figure 4.4. SDS-PAGE analysis of His6-TEV-Hp0100 (pUD010) purification. (A) Ni+2HiTrap Chelating Hi Performance affinity chromatography purification of Hp0100. Pellet
(lane 1), lysate (lane 2), flow through (lane 3), 0 mM imidazole wash (lane 4), 2.5 mM
imidazole wash (lane 5 and 6), 250 mM imidazole elution (lane 7), and concentrated
elution (lane 8). (B) Cation exchange chromatographic purification of Hp0100 from A. 0
mM NaCl (a), 100 mM NaCl (b), 200 mM NaCl (c), 300 mM NaCl (d), 400 mM NaCl (e),
and 500 mM NaCl (f). (C) TEV protease cleavage analysis. TEV protease cleaved
Hp0100 sample (lane 1) and the elution after TEV protease (lane 2).
4.2.4 Cloning, overexpression and purification of His6-SUMO-TEV-Hp0100
We also cloned the WT and codon optimized hp0100 genes into a vector with a
small Ubiquitin-like Modifier (SUMO) tag. The pET-His6-SUMO-TEV-LIC cloning vector
(2S-T) appends a TEV protease cleavable N-terminal His6-SUMO tag to the cloned gene.
We tested different overexpression conditions, and some are shown in Figure 4.5. None
of the tested conditions yielded appreciable amounts of soluble protein.
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Figure 4.5. SDS-PAGE analysis of overexpression of SUMO tagged Hp0100 in E.
coli BL21(DE3)-RIL cell line. (A) Analysis of His6-SUMO-TEV-WT Hp0100
overexpression from pUD011. (B) Analysis of His6-SUMO-TEV-codon optimized Hp0100
overexpression from pUD012. (1) One-hour induction with 1 mM IPTG at 0.8-1 OD600 at
37 °C; (2) 4-hour induction with 1 mM IPTG at 0.4-0.6 OD600 at 37 °C; and, (3) overnight
induction with 1 mM IPTG at 0.4-1 OD600 at 19 °C. Each lane contains 20 g total protein.
The arrow indicates the size of the His6-SUMO-TEV-Hp0100 protein. Un: uninduced; In:
Induced; P: pellet; and, L: lysate
4.3 Discussion
Since we hypothesized that the misacylated tRNA-dependent ATPase activity of
Hp0100 depends on the binding of metals to Hp0100 protein, we set out to clone,
overexpress, and purify Hp0100 without a His6, metal-binding tag. We cloned the H. pylori
hp0100 gene (WT and codon-optimized to express in E. coli) into multiple expression
vectors introducing untagged or cleavable N-terminal tags.
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The untagged WT hp0100 in the pQE-80L expression vector was tested for protein
overexpression under various conditions: different cell lines, growth temperatures,
inducer concentrations, induction times, etc. Growth at a lower temperature and longer
induction time resulted in considerable overexpression of protein compared to uninduced
culture control. To overcome the problem with the solubility, the cell pellets were
resuspended in higher salt (1 M NaCl) containing buffers. Different purification methods
were tested to obtain pure Hp0100 protein. Ammonium sulfate precipitation followed by
cation exchange chromatography resulted in more pure protein compared to all other
methods examined. But the yield and the activity assays with this Hp0100 were not
reliably reproducible.
One of the major problems in expressing Hp0100 is its insolubility. Lowering
overexpression temperature, inducer concentration, and various induction times didn’t
improve solubility. Further, the use of different lysis buffers with high salt, use of
detergents such as Triton X-100, and incorporation of chaotropic agents such as urea
also don’t increase the solubility of the protein.
To overcome the issues with protein insolubility, we introduced a SUMO tag to the
N-terminal of the Hp0100 protein. The SUMO tag has proven to be useful for enhancing
the solubility as well as the expression of proteins in E. coli expression systems (134135). Unfortunately, in our case, we did not see an improvement in the overexpression or
solubility of Hp0100 with the tested conditions.
The clone with an N-terminal TEV protease cleavable His6-tag Hp0100
overexpressed well compared to other tested clones and also resulted in soluble protein.
The purification of this protein construct was also straightforward. Lysis was carried out
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in phosphate buffer with high salt and the protein was purified by Ni+2 affinity followed by
cation exchange chromatography. Finally, the pure protein was subjected to TEV
protease cleavage to remove the appended His6-tag. Although we were able to get pure
Hp0100 using this construct, the TEV cleavage was unsuccessful. Since sonication
sometimes results in protein aggregation (136) and osmotic lysis was proven to work with
problematic TEV protease (137) cleavages, we also tried using osmotic lysis and TEV
protease cleavage with this protein construct. But, this method did not enhance TEV
protease cleavage.
In conclusion, in this chapter, we have described our unsuccessful efforts to purify
Hp0100 using a variety of expression vectors with different N-terminal purification tags.
With each clone, we encountered challenges during protein expression, solubilization, or
purification. Parallel efforts have led to the successful cloning and purification of S. aureus
Sa2591 (138), a truncated ortholog of Hp0100 that only contains 2/3 of its N-terminal
primary sequence. This success suggests that the solubility and overexpression issues
described herein may be due to the extra domain in the C-terminal of full length Hp0100
protein. Further experiments need to be done to confirm this assumption.
4.4 Materials and Methods
4.4.1 Materials
Sodium dihydrogen phosphate (NaH2PO4), magnesium chloride, cOmplete mini
protease inhibitor tablets, and DNA oligos were purchased from Sigma-Aldrich (St. Louis,
MO). Ampicillin, chloramphenicol, ethylenediaminetetraacetic acid (EDTA), isopropyl D-thiogalactopyranoside (IPTG), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES), lysozyme, and phenylmethanesulfonyl fluoride (PMSF) were from Gold
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Biotechnology, Inc., (St. Louis, MO. Sodium chloride (NaCl). Restriction enzymes, T4
DNA ligase, and Calf Intestinal Alkaline Phosphatase (CIP) were purchased from New
England Biolabs (NEB, Ipswich, MA). E.Z.N.A.® Plasmid Mini kit II was from Omega BioTek (Norcross, GA).
4.4.2 Cloning of untagged WT and mutant Hp0100
Plasmids containing WT and different mutant hp0100 genes (pTC034, pGS018,
pGS022, pGS023, and pGS024) were digested with EcoRI and BamHI restriction
enzymes to remove the His6-tag coding sequence. Then, primers containing the
intervening

DNA

sequence

without

the

His6-coding

sequence

(CACCATCACCATCACCAT) were inserted into the EcoRI and BamHI digested plasmids
to create untagged Hp0100 encoding plasmids. The sequences of the primers used were
as follows; these primers contain complementary overhangs to the EcoRI and BamHI
digested plasmids:
Forward primer UD005:
5’-AATTCATTAAAGAGGAGAAATTAACTATGAGAGGATCGG-3’
Reverse primer UD006:
5’-GATCCCGATCCTCTCATAGTTAATTTCTCCTCTTTAATG-3’
The primers (UD005 and UD006) were mixed in equal molar ratios and the primer
mixture was added to double digested plasmids in different primer:plasmid ratios. A T4
DNA ligase reaction was performed according to the manufacturer’s protocol (NEB). The
ligation reactions were transformed into E. coli DH5 calcium chloride competent cells
and were plated on Luria Bertani (LB) plates supplemented with ampicillin (100 g/mL)
and glucose (0.5%). Plasmids were isolated from individual colonies and the entire gene
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was sequenced at the Applied Genomics Technology Center (AGTC), Wayne State
University.

The

plasmid

pGS024

(His6-Hp0100(S84A))

resulted

in

untagged

Hp0100(S84A) mutant plasmid after the cloning process. This new plasmid was named
pUD002.
pUD002 was subjected to site-directed mutagenesis to create a plasmid encoding
WT untagged Hp0100 (pUD003). PCR mutagenesis was carried out according to the
instructions provided by Stratagene (La Jolla, CA) using the primers listed below. Site
directed-mutagenesis indicated in red letters.
Forward mutagenesis primer UD010:
5’-GGAATTGTTAGGGGAAAAAAGCGAACGCTGTTTTGAGTGCTTTG-3’
Reverse mutagenesis primer UD011:
5’-CAAAGCACTCAAAACAGCGTTCGCTTTTTTCCCCTAACAATTCC-3’
4.4.2 Overexpression and purification of untagged WT Hp0100
Untagged WT Hp0100 (pUD003) was overexpressed in E. coli DH5 by
inoculating LB medium (1L) supplemented with glucose (0.5%) and ampicillin (100 g/mL)
with a saturated overnight culture (10 mL) grown in the same medium. The culture was
grown at 19 °C, 200 rpm until the OD600 reached between 0.4 and 1. Protein
overexpression was induced with IPTG (1 mM) and another round of ampicillin (100
g/mL) was added. After 16-18 hours of protein induction, the cells were harvested by
centrifugation at 4000 rpm for 10 min at 4°C.
The cell pellet was suspended in lysis buffer (50 mM NaH2PO4 pH 7.4, 1 M NaCl)
and cells were lysed using lysozyme (2 mg/mL). A cOmplete protease inhibitor cocktail
tablet was added to reduce proteolysis and incubated on ice for 30 min. The cell
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suspension was sonicated 10 times using a Misonix MicrosonTM Ultrasonic cell Disruptor
set at power level 4 for 10 s with 50 s rest cycles on ice between each pulse. The cell
debris was removed by centrifugation at 14,000 rpm for 30 min at 4 °C. Ammonium sulfate
was added to the clear cell lysate to 50% saturation and the mixture was rotated at 4 °C
for 30 min. The protein was recovered by centrifugation at 14,000 rpm for 30 min at 4 °C
and dissolved in dialysis buffer (20 mM HEPES, pH 7.4, 200 mM NaCl). The protein
sample was dialyzed in 2 L of the same buffer for 2 hours and again against 2 L overnight.
The filtered sample (~ 2 mL) was loaded onto a UNO S ion-exchange column (12 mL
column volume, BIO-RAD, Hercules, CA). The protein was eluted with an increasing
gradient of NaCl. Protein fractions were concentrated using an Amicon 30 kDa MWCO
tube (EMD Millipore, Burlington, MA) and the purity of Hp0100 was analyzed by SDSPAGE.
4.4.3 Cloning and overexpression of GST-Hp0100
The WT hp0100 gene from pUD003 was subcloned into the pGEX-4T3 expression
vector using BamHI and XmaI restriction sites. This cloning results in hp0100 with 5’-GST
tag with an intervening thrombin cleavage site. pUD003 and pGEX-4T3 plasmids were
digested with BamHI and XmaI restriction endonuclease according to manufactures
protocol. The insert and vector were gel purified. Calf Intestinal Alkaline Phosphatase
(CIP) was used to remove the 5’ and 3’ phosphates from the digested vector. T4 DNA
ligase reactions were performed using different vector:insert ratios (1:1, 1:2, 1: 5, and
1:10). The ligation reactions were transformed into E. coli DH5 chemically competent
cells and plated on LB plates supplemented with ampicillin (100 g/mL) and glucose
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(0.5%). Plasmids were purified from single colonies and the correct sequence was
confirmed by sequencing. The resultant plasmid was named pUD007.
The pUD007 plasmid was transformed into E. coli Bl21(DE3)-RIL chemically
competent cells and plated on plates with ampicillin (100 g/mL), chloramphenicol (100
g/mL), and glucose (5%). LB cultures (50 mL) supplemented with ampicillin (100 g/mL),
chloramphenicol (100 g/mL), and glucose (5%) were inoculated with a saturated
overnight culture grown from a single colony. The cultures were incubated at 37 °C until
the OD at 600 nm reached ~0.4-0.6. Protein overexpression was induced with 1 mM IPTG
at 19 °C overnight and at 37 °C for 4 hours. Cells were pelleted and lysed in lysis buffer
(50 mM NaH2PO4 pH 7.4, 300 mM NaCl) with lysozyme (2 mg/mL) and sonication. PMSF
was added every 15-20 min to reduce proteolysis. The lysate and cell debris were
analyzed by SDS-PAGE.
4.4.4 Cloning, overexpression and purification of His6-TEV-Hp0100
A TEV protease recognition sequence was inserted in between the His 6-tag and
the start codon of hp0100 gene (pTC034). The insertion of the TEV protease site allows
removal of the polyhistidine tag after purification. The plasmid pTC034 (His6-WT Hp0100
in pQE-80L) was digested with BamHI. The digested plasmid was treated with CIP to
remove the 5’ and 3’ phosphates. DNA oligos containing the TEV protease recognition
sequence and complementary overhangs to the BamHI were as follows:
Forward primer UD015:
5’-GATCCGAAAACCTGTACTTCCAAGGCGGTACCG-3’
Reverse primer UD016:
5’-GATCCGGTACCGCCTTGGAAGTACAGGTTTTCG-3’
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These primers (UD015 and UD016) were mixed together in equimolar ratios. The
mixture was heated up to 75 °C and slowly cooled to room temperature to anneal the
primers. The primer mixture was added to the BamHI-digested pTC034 DNA in different
molar ratios. T4 DNA ligase reactions were performed according to the manufacturer’s
instructions (NEB). The reactions were transformed into E. coli DH5 calcium chloride
chemically competent cells and plated onto LB plates supplemented with ampicillin (100
g/mL) and glucose (0.5%). The correct DNA sequence was confirmed by sequencing
(pUD009).
The hp0100 gene with codon optimized for expression in E. coli with a 5’-TEV
protease cleavage sequence and was chemically synthesized and inserted into the
pUC57 vector by GenScript (GenScript Biotech Corp., Piscataway, NJ). The codonoptimized TEV-hp0100 gene was subsequently cloned into the pQE-80L expression
vector using BamHI and SalI restriction sites (pUD010). The correct sequence was
confirmed by sequencing.
His6-TEV-optimized Hp0100 was overexpressed from pUD010 in E. coli DH5.
Overexpression examined under different conditions. Culture of LB media (50 mL)
supplemented with glucose (0.5%) and ampicillin (100 g/mL) was inoculated with a
saturated overnight culture grown in the same medium. The cultures were grown at two
different temperatures, 37 °C and 19 °C. The cultures grown at 37 °C was induced with
IPTG (0.1 mM versus 1 mM) when their OD600 reached 0.4-0.6 and protein induction was
carried out for 4 hours. Another set of cultures that were grown at 37 °C and induced with
IPTG (0.1 mM and 1 mM) when their OD600 reached 0.8-1 and protein induction was
carried out for one hour. For the cultures incubated at 19 °C, protein expression was
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induced when their OD600 reached between 0.4 and 1 by adding IPTG (0.1 mM and 1
mM) for 16-18 hours. For these cultures, another round of ampicillin (100 g/mL) was
added after 24 hours. Cells were pelleted and lysed in lysis buffer (50 mM NaH2PO4, pH
7.4, 300 mM NaCl) with lysozyme (2 mg/mL) and sonication. PMSF was added every 1520 min to reduce proteolysis. The lysate and cell debris were analyzed by SDS-PAGE.
The protein expression at 19 °C with 1 mM IPTG for 16-18 hours was used as the
optimized overexpression condition.
The cell pellet was resuspended in lysis buffer (50 mM NaH2PO4 pH 7.4, 1 M NaCl)
and the cells were lysed using lysozyme (2 mg/mL). A protease inhibitor cocktail tablet
was added to reduce proteolysis and the suspension was incubated on ice for 30 min
prior to sonication. After sonication, cell debris was removed by centrifugation at 14,000
rpm for 30 min and the clear lysate was filtered through 0.8 m and 0.2 m syringe filters
(Pall Corporation, Port Washington, NY). The protein sample was injected onto a HiTrap
Ni+2 Chelating Hi-Performance (HP) affinity chromatography column (GE Healthcare Life
Sciences, Pittsburg, PA). The column was washed with wash buffer (50 mM NaH2PO4
pH 7.4, 300 M NaCl, and 2.5 mM imidazole) and Hp0100 was eluted with elution buffer
(50 mM NaH2PO4 pH 7.4, 300 M NaCl, and 250 mM imidazole). The elution was dialyzed
in dialysis buffer (2 L, 20 mM HEPES, pH 7.4) at 4 °C for 2 hours and against another
round of dialysis buffer at 4 °C overnight. The protein sample was concentrated (~2 mL)
and injected onto a UNO S ion-exchange column (12 mL column volume, BIO-RAD,
Hercules, CA). The protein was eluted with a stepwise gradient of NaCl.
TEV protease cleavage was performed on the combined and concentrated His 6TEV-Hp0100 fractions after cation exchange chromatography. His 6-TEV protease was
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added to the purified His6-TEV-Hp0100 protein in a ratio of 1 mg of TEV protease to ~5
mg of Hp0100. The reaction was diluted using dialysis buffer A (~15 mL, 50 mM NaH2PO4
pH 7.4, 300 M NaCl, 0.5 mM Na2EDTA, 10 mM -mercaptoethanol) and dialyzed in
dialysis buffer (2 L) at 4 °C overnight to remove the polyhistidine tag. The dialysis buffer
was exchanged to dialysis buffer B (2 L, 50 mM NaH2PO4 pH 7.4, 300 mM NaCl, 0.1 mM
EDTA) and dialyzed at 4 °C for 1-2 hours. The His6-tagged TEV protease and the
uncleaved His-tagged Hp0100 were removed by passing the reaction through HiTrap Ni+2
chelating HP affinity column. The flow-through contained the untagged Hp0100.
4.4.5 Cloning and overexpression of His6-SUMO-TEV-Hp0100
The WT and codon-optimized hp0100 genes were cloned into the pET His6 SUMO
TEV LIC cloning vector (2S-T, Addgene, Watertown, MA) to incorporate a cleavable Nterminal SUMO tag onto the hp0100 gene using the ligation independent cloning (LIC)
protocol from QB3 Macro lab, California Institute for Quantitative Biosciences (pUD011
and pUD012). The primers used in LIC is listed in table 4.2.
Table 4.2. Oligonucleotide sequence used in LIC.
Primer

Sequence

UD018 TACTTCCAATCCAATGCAATGCTCATTCATATTTGCTGCTC

Plasmid

pUD011

TTATCCACTTCCAATGTTATTATTACAGCAAATAAAACACC
UD019
TTTTCTTC
UD020 TACTTCCAATCCAATGCAATGCTGATCCACATTTGCTG
TTATCCACTTCCAATGTTATTATTACAGCAGATAGAACACT
UD021
TTTTCTTCC

pUD012
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The His6-SUMO-TEV-WT Hp0100 (pUD0010) and His6-SUMO-TEV-codon
optimized Hp0100 (pUD012) plasmids were overexpressed in E. coli BL21(DE3)-RIL by
inoculating a culture of LB medium (50 mL) supplemented with ampicillin (100 g/mL),
chloramphenicol (100 g/mL), and glucose (0.5%) with a saturated overnight culture
grown in the same medium. The cultures were grown at two different temperatures: 37
°C and 19 °C. The cultures incubated at 37 °C were induced with IPTG (1 mM) at various
OD600 (0.4-0.6 and 0.8-1) for 4 hours and 1 hour, respectively. The cultures that were
grown at 19 °C were induced at OD600 0.4-1 with IPTG (1 mM) overnight. The cells were
lysed and analyzed by SDS-PAGE.
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CHAPTER 5
PRELIMINARY CHARACTERIZATION OF SA2591, A TRUNCATED ORTHOLOG OF
HP0100, A PROTEIN INVOLVED IN INDIRECT TRNA AMINOACYLATION
5.1 Introduction
As discussed earlier in this dissertation, Hp0100 is an essential component of the
H. pylori Asn-transamidosome (79). Apart from making a tRNA-independent
transamidosome, Hp0100 accelerates the GatCAB-catalyzed transamidation of AsptRNAAsn to Asn-tRNAAsn by ~35 fold (79) and of Glu-tRNAGln to Gln-tRNAGln by ~3 fold
(87). Further, Hp0100 has two putative ATPase domains; namely, an AANH domain and
a P-loop motif. These two domains are activated by the two misacylated tRNAs produced
during indirect tRNA aminoacylation: The AANH domain is activated by Glu-tRNAGln, and
the P-loop is activated by Asp-tRNAAsn (87). Previous work in our lab also suggests that
Hp0100 has a metal binding motif with a CXXC consensus sequence (87, 138), although
the functional role of this metal-binding site is unknown. These results highlight the
importance of Hp0100 in the indirect biosynthesis of Asn-tRNAAsn and Gln-tRNAGln in H.
pylori.
Even though full-length orthologs of Hp0100 are found only in -proteobacteria,
truncated orthologs have been found in many other bacteria. These truncated versions
contain roughly 2/3 of the primary N-terminal sequence of Hp0100. Importantly, these
truncated variations were found in 7 of 18 of the drug-resistant strains listed as the
“biggest threats” by the Center for Disease Control (CDC), USA (139). A partial sequence
alignment of Hp0100 with the truncated orthologs found in methicillin-resistant S. aureus
(MRSA, a firmicute; Sa2591) and Neisseria gonorrhoeae (N. gonorrhoeae, a proteobacteria causes the sexually-transmitted disease gonorrhea; NG0682) is shown in
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Figure 5.1. These truncated orthologs contain the AANH and P-loop ATPase active site
motifs (Figure 5.1A and B) critical to Hp0100 function. Furthermore, both bacteria use
indirect tRNA aminoacylation. N. gonorrhoeae has a functional GlnRS but lacks AsnRS
(140), so indirect tRNA aminoacylation is only used in the production of Asn-tRNAAsn. In
contrast, S. aureus has AsnRS but lacks both GlnRS and AsnS, the enzyme that
biosynthesizes asparagine (48). Therefore, the indirect tRNA aminoacylation pathway is
utilized in producing Gln-tRNAGln and in tRNA-dependent asparagine synthesis.
As shown in Figure 5.1, Sa2591 contains about 2/3 of the N-terminal sequence of
Hp0100 and shares about 29% of sequence identity. This truncated ortholog contains
both ATPase domains and the same CXXC motif found in Hp0100 (Figure 5.1B, blue
box). Additionally, model structures of Hp0100 and Sa2591 (generated using the Robetta
(89) and I-TASSER (141) respectively) show structural similarities between these two
proteins (Figure 5.2).
Since S. aureus uses indirect tRNA aminoacylation to produce both Asn-tRNAAsn
and Gln-tRNAGln and Hp0100 and Sa2591 have sequence and structural similarities, we
hypothesized that Sa2591 may function in a similar way to Hp0100.
In the early characterization of Hp0100, Dr. Gayathri Silva observed that
purification of His6-Hp0100 from E. coli resulted in co-purification of E. coli AspRS (87).
Similarly, Dr. Whitney N. Wood demonstrated that E. coli AspRS co-purifies with His6Sa2591 (Figure 5.3A), offering the first experimental evidence that Sa2591 is a functional
ortholog of Hp0100 (138).
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Figure 5.1. Sequence similarities between Hp0100 and two putative truncated
orthologs Sa2591 and Ng0682. (A) A cartoon schematic comparing the position of the
AANH and P-loop domains in Hp0100 and the truncated orthologs from S. aureus
(Sa2591) and N. gonorrhoeae (Ngo0682). (B) An alignment of the AANH domain and Ploop sequences from all three proteins. Motif-specific residues are colored in red.
Rigorously conserved residues are labeled with an asterisk, colons mark highly
conserved, and periods mark loosely conserved positions. The conserved CXXC motif in
P-loop is boxed in blue.
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Figure 5.2. Structural similarities between Hp0100. (A) An overlay of the model
structures of Hp0100 (grey) and Sa2591 (cyan). (B) A close-up of the two AANH domains.
(C) A close-up of the two P-loop motifs.

Figure 5.3. E. coli AspRS co-purifies with Sa2591. (A) SDS-PAGE gel showing copurified E. coli AspRS with Sa2591. Lanes represent different fractions from an SEC
purification. Sa2591 in noted in the green box and E. coli AspRS is shown in the red box.
(B) Aminoacylation assays to confirm E. coli AspRS activity. Fractions 1 and 2 from panel
A were assayed for AspRS activity. Fraction 1 produces Asp-tRNAAsp over time,
confirming the identity of AspRS. Fraction 2 was assayed for comparison. Figure provided
by Dr. Whitney Wood (138).
Also, like Hp0100, Sa2591 hydrolyzes ATP to ADP and Pi and this activity is
enhanced in the presence of misacylated Asp-tRNAAsn (Figure 5.4) (138). Dr. Whitney
Wood used a spectrophotometric enzyme-coupled assay to detect ADP production over
time in the presence of Sa2591. In this assay, NADH oxidation to NAD + is directly
correlated to the hydrolysis of ATP to ADP. Since NADH absorbs light at 340 nm and
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NAD+ does not, any decrease in absorbance at 340 nm indicates ATP hydrolysis (Figure
5.4). Most importantly, Dr. Wood observed that the ATPase activity of Sa2591 is only
weakly stimulated by in vitro transcribed, misacylated Asp-tRNAAsn, compared to posttranscriptionally modified (overexpressed in vivo) misacylated Asp-tRNAAsn (Figure 5.4B
and D, respectively). Moreover, Sa2591’s ATPase activity is not affected by the
presence of correctly aminoacylated Asp-tRNAAsp (Figure 5.4A and C). These results
suggest the importance of post-transcriptional modifications to the ATPase activity of
Sa2591 (138).
So far, we have demonstrated that Sa2591 might be a functional ortholog of
Hp0100 with respect to its ATPase activity. In this chapter, we focus on further
characterization of Sa2591, particularly regarding its effect on the GatCAB-catalyzed
transamidation of Asp-tRNAAsn to Asn-tRNAAsn. The advantage of continuing this work
with Sa2591, instead of Hp0100, is that it is much more readily and reliably purified in
active form (see Chapter 4).
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Figure 5.4. Sa2591 is an ATPase that is activated by misacylated tRNAs. (A) Sa2591
ATPase assays with in vivo transcribed correctly acylated tRNAs. ATPase activity is not
stimulated by transcribed, misacylated Asp-tRNAAsn. (B) Sa2591 ATPase assays with in
vivo transcribed misacylated tRNAs. ATP hydrolysis is stimulated by fully modified,
misacylated Asp-tRNAAsn. (C) Sa2591 ATPase assays with in vitro transcribed correctly
aminoacylated tRNAs. (D) Sa2591 ATPase assays with in vitro transcribed misacylated
tRNAs. ATP hydrolysis is weakly stimulated by misacylated in vitro transcribed AsptRNAAsn compared to in vivo transcribed Asp-tRNAAsn. Figure provided by Dr. Whitney
Wood (138).
5.2 Results
5.2.1 Sa2591 does not affect the GatCAB-catalyzed transamidation of in vitro
transcribed S. aureus Asp-tRNAAsn to Asn-tRNAAsn
To further investigate Sa2591 as a functional ortholog of Hp0100, we assayed the
impact of this enzyme on GatCAB-catalyzed transamidation of Asp-tRNAAsn to AsntRNAAsn. To this end, we utilized a P1 nuclease transamidation assay (Figure 5.5). In this
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assay, the 3’ end of tRNAAsn was first labeled with -32P-AMP. Then, this
tRNAAsn sample was aminoacylated with aspartate by ND-AspRS.

32P-labeled

Next, GatCAB-

catalyzed transamidation reactions were carried out in the presence and absence of
Sa2591. After digestion with P1 nuclease, the

32P

radiolabel allows the conversion of

aspartate to asparagine to be monitored via TLC separation of Asp-AMP and Asn-AMP
and phosphorimaging.
Yields of S. aureus tRNAAsn were low when overexpressed in E. coli MV1184. For
this reason, we prepared in vitro transcribed tRNAAsn for use in transamidation assays.
This tRNA was readily aminoacylated by S. aureus ND-AspRS to produce Asp-tRNAAsn
and converted to Asn-tRNAAsn by GatCAB. However, unlike Hp0100, Sa2591 did not
show any effect on this transamidation activity (Figure 5.6). These results also suggest
that Sa2591 may distinguish between transcribed and post-transcriptionally modified
tRNAs, a hypothesis that requires further analysis.
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Figure 5.5. Schematic representation of P1 nuclease transamidation assay. AsptRNAAsn is labeled with -32P-AMP using the CCA-adding enzyme and then
aminoacylated by ND-AspRS. Following incubation with GatCAB in the presence and
absence of Sa2591, the tRNA is digested with P1 nuclease, and Asp-AMP and Asn-AMP
are separated by TLC. The radiolabel is quantified by phosphorimager. Figure modified
from one provided by Dr. Gayathri Silva.

Figure 5.6. Sa2591 does not affect Asn-tRNAAsn production by GatCAB. (A) A
representative phosphorimage of the results of a GatCAB (10 nM) transamidation
reaction converting Asp-tRNAAsn (5 M, indicated by Asp-AMP) into Asn-tRNAAsn
(indicated by Asn-AMP) in the absence and presence of Sa2591 (500 nM). (B) Initial rates
of Asn-tRNAAsn production, quantified from triplicate TLC plates as in A. (C) Bar graph
representation of relative rates for the transamidation activity of GatCAB in the presence
and absence of Sa2591. Error bars represent the standard error of the mean from
triplicate measurements.
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5.2.2 S. aureus GatCAB does not transamidate H. pylori Asp-tRNAAsn
To evaluate our hypothesis that post-transcriptional modifications are important for
Sa2591 activity, we next investigated the effect of Sa2591 on GatCAB with modified
tRNAs. Unfortunately, as noted above, S. aureus tRNAAsn is not produced in significant
yields when overexpressed in E. coli. Consequently, we performed the same
transamidation assays as above using modified H. pylori tRNAAsn. Dr. Whitney Wood had
observed ATPase activity enhancement when Sa2591 was incubated with H. pylori
tRNAAsn (138), leading us to anticipate that this heterologous combination of H. pylori
tRNAAsn, Sa2591, and S. aureus GatCAB would be effective. Unfortunately, H. pylori AsptRNAAsn is not a robust substrate for S. aureus GatCAB, at least according to the
preliminary results shown in Figure 5.7. Hence, the effect of Sa2591 on the
transamidation activity of GatCAB remains undetermined.

Figure 5.7. H. pylori Asp-tRNAAsn is a poor substrate for S. aureus GatCAB. A
representative phosphorimage of an S. aureus GatCAB (10 nM) transamidation reaction
with H. pylori Asp-tRNAAsn (5 M) in the absence and presence of Sa2591 (500 mM). (+)
indicates an Asn-tRNAAsn positive control and (-) represents Asp-tRNAAsn as a negative
control.
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5.3 Discussion
Many bacteria that lack AsnRS (and/or AsnS) and/or GlnRS utilize an indirect
biosynthesis pathway to produce Asn-tRNAAsn (and/or asparagine) and Gln-tRNAGln (34).
These two tRNAs are first misacylated to form Glu-tRNAGln and Asp-tRNAAsn, reactions
that are catalyzed by ND-GluRS (100) (or GluRS2 in H. pylori (41-42)) and an ND-AspRS
(43, 49), respectively. Then, these misacylated tRNAs are converted to Gln-tRNAGln and
Asn-tRNAAsn by an amidotransferase called GatCAB (15, 36, 44). The assembly of a
stable ribonucleoprotein complex from tRNAAsn, GatCAB, and ND-AspRS, called the Asntransamidosome, prevents premature release of Asp-tRNAAsn prior to repair by GatCAB
and ensures the fidelity of protein synthesis (77-78, 82).
In contrast to the tRNA-dependent, Asn-transamidosome complexes from T.
thermophilus and P. aeruginosa, H. pylori Asn-transamidosome formation depends on
another protein partner called, Hp0100, instead of tRNAAsn (79). Hp0100 is an ATPase
with two distinct ATPase sites which are activated by two different misacylated-tRNAs.
Hp0100 also enhances the GatCAB-catalyzed transamidation of Asp-tRNAAsn to AsntRNAAsn and Glu-tRNAGln to Gln-tRNAGln (79, 87).
We have discovered several truncated orthologs of Hp0100 that contains 2/3 of
the primary N-terminal sequence of Hp0100 from other bacteria. Here, we turned our
focus onto the characterization of the truncated ortholog from S. aureus, called Sa2591.
Because of their sequence and predicted model structural similarities (Figure 5.1 and 5.2
respectively), we hypothesized that Sa2591 would be functionally similar to Hp0100.
Dr. Whitney Wood showed that Sa2591 co-purifies with E. coli AspRS (Figure
5.3) (138), suggesting possible Asn-transamidosome formation in S. aureus. Further, Dr.
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Wood confirmed that Sa2591 is an ATPase and catalyzes the hydrolysis of ATP to ADP
(138). The Sa2591 ATPase activity is enhanced in the presence of misacylated tRNAs
(Figure 5.4) specifically when these tRNAs are produced in vivo such that they contain
post-transcriptional tRNA modifications (Figure 5.4B and D) (138).
As shown in Figure 5.6, Sa2591 does not show any influence on the GatCABcatalyzed transamidation of Asp-tRNAAsn into Asn-tRNAAsn, distinguishing this protein
from Hp0100. However, this divergence may be due to a lack of one or more posttranscriptional modifications in tRNAAsn. Future research is needed with modified S.
aureus tRNAs to address this hypothesis.
Recently, Hp0100 and Sa2591, members of the DUF208 family of proteins of
unknown function, were identified for their probable role in queuosine biosynthesis (99).
Queuosine is a post-transcriptionally modified nucleotide found in the first position of the
anticodon of four different tRNAs: tRNAAsp, tRNAAsn, tRNAHis, and tRNATyr (94). The last
step of queuosine biosynthesis pathway is the reduction of epoxyqueuosine to queuosine;
this reaction was known to be characterized by a cobalamin-dependent enzyme called
QueG (Chapter 1, Figure 1.12) (98, 142). However, in bacteria that lack QueG, the
DUF208 family proteins act as epoxyqueuosine reductase and catalyze the last step in
queuosine biosynthesis (99).
Pulling our preliminary results characterizing Sa2591, our published and
unpublished results with Hp0100, and the reclassification of these enzymes as queuosine
reductase (QueH), we believe that Sa2591 has different activities under different growth
conditions. Under favorable growth conditions, Sa2591 would be involved in forming a
stable Asn-transamidosome structure as we’ve demonstrated with Hp0100 (79).
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However, under unknown stress conditions, Sa2591 may dissociate from the
transamidosome to act as a queuosine reductase. Such a dissociation event would also
allow for misincorporation of aspartate into proteins at asparagine codons as is the case
in M. tuberculosis and M. smegmatis (50, 76). It is known that the levels of modified
nucleotides in tRNAs, especially at anticodon wobble positions, increases during stressinduced conditions (143). Interestingly, Sa2591 mRNA transcripts are upregulated in S.
aureus in acid-shocked cells, providing additional support to this hypothesis (144).
In conclusion, Sa2591 is a multi-functional protein as Hp0100. Due to this multifunctional nature of this protein is makes the data interpretation and characterization of
this protein complicated. Further experiments needed to asses these activities of Sa2591
under favorable and stress-related growth environments.
5.4 Materials and Methods
5.4.1 Materials
Sodium dihydrogen phosphate (NaH2PO4), L-aspartic acid, magnesium chloride,
inorganic pyrophosphatase and diethyl pyrocarbonate (DEPC) were purchased from
Sigma-Aldrich (St. Louis, MO). All radiolabeled reagents were purchased from American
Radiolabeled Chemicals (St. Louis, MO). Ampicillin, chloramphenicol, kanamycin,
ethylenediaminetetraacetic acid (EDTA), tris(hydroxymethyl) aminomethane (Tris),
isopropyl -D-thiogalactopyranoside (IPTG), dithiothreitol (DTT), bovine serum albumin
(BSA), and phenylmethanesulfonyl fluoride (PMSF) were from Gold Biotechnology, Inc.,
(St. Louis, MO). Sodium chloride (NaCl), and ammonium acetate (NH 4OAc) were
purchased from Fisher Scientific (Hampton, NH). BstNI was purchased from New
England Biolabs (NEB, Ipswich, MA).
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5.4.2 Overexpression and purification of S. aureus Sa2591
S. aureus Sa2591 with an N-terminal TEV protease cleavable His6-tag
(pWNW003) was overexpressed in DH5. LB medium (0.5 L) supplemented with
ampicillin (100 g/mL) and glucose (0.5%) was inoculated with a saturated overnight
culture grown from a single colony. The cultures were incubated at 37 °C, 200 rpm until
the OD600 of 0.4-0.6, and protein expression was induced with IPTG (1 mM). After
induction, the cultures were grown at 19 °C for 14-16 hours and the cells were collected
by centrifugation.
The cell pellet was suspended in lysis buffer (50 mM NaH2PO4 pH 7.4, 1 M NaCl,
10 mM imidazole, 1 mM -mercaptoethanol). The cells were lysed with lysozyme (2
mg/mL) and sonication. Aliquots of saturated PMSF (15 L/mL) were added every 15-20
min to reduce proteolysis. The cell debris was removed by centrifugation at 14,000 rpm
for 30 min at 4 °C. The filtered lysate was loaded onto HiTrap Chelating High Performance
(HP) affinity column (GE Healthcare Life Sciences, Pittsburg, PA), which was loaded with
Ni2+. The His6-TEV-Sa2591 protein was purified essentially according to the
manufacturer’s protocol (GE Healthcare Life Sciences), with buffers containing mercaptoethanol (1 mM). The eluent was diluted with dialysis buffer A (~10 mL, 50 mM
NaH2PO4 pH 7.4, 300 mM NaCl, 0.5 mM Na2EDTA, 10 mM -mercaptoethanol) and TEV
protease was added in a ratio of 1 mg TEV to ~5 mg of tagged Sa2591. The cleavage
reaction was dialyzed in dialysis buffer A (2 L) at 4 °C overnight and against dialysis buffer
B (2 L, dialysis buffer A with 1 mM -mercaptoethanol) for 1-2 hours. The cleaved His6tag and His6-TEV protease were removed by passing through a Ni2+-coordinated HiTrap
Chelating HP affinity column. The untagged Sa2591 was in the flow through and the
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protein was concentrated using an Amicon 10 kDa MWCO (EMD Millipore, Burlington,
MA). Final protein concentrations were determined by UV-Vis spectroscopy at 280 nm,
using the extinction coefficient obtained from the ExPASy ProtParam tool (133). The
protein was stored in glycerol (50%) at -20 °C and is stable for ~ 1 week after purification.
5.4.3 Overexpression and purification of S. aureus ND-AspRS
The S. aureus ND-AspRS (vector provided by Dr. Kelly Sheppard) was
overexpressed in E. coli BL21(DE3)-RIL cell line and purified as previously described
(51).
5.4.4 Overexpression and purification of S. aureus GatCAB
S. aureus GatCAB plasmid (vector provided by Dr. Isao Tanaka (60)) was
overexpressed in E. coli BL21(DE3)-RIL. The culture was grown beginning with a single
colony, in LB medium (1 L) supplemented with kanamycin (25 g/mL), chloramphenicol
(100 g/mL), and glucose (0.5%) at 37 °C. Protein expression was induced with IPTG (1
mM) when the OD600 reached 0.4-0.6. After 4 hours, cells were harvested by
centrifugation at 4000 rpm for 10 min at 4 °C. The cells were resuspended in lysis buffer
(50 mM NaH2PO4 pH 7.4, 300 mM NaCl, 10 mM imidazole) containing saturated PMSF
(15 L/mL) and lysozyme (2 mg/mL). The cell suspension was incubated on ice for 30
min and sonicated 6-10 times using a Misonix MicrosonTM Ultrasonic Cell Disruptor set
at level 4 for 10 seconds, with 50 second recovery intervals on ice between each pulse.
After centrifugation at 14,000 rpm for 30 min at 4 °C, the lysate was added to a PolyPrep
column that contained High-density cobalt agarose beads (~ 2 mL, Gold Biotechnology,
Inc.) pre-washed with lysis buffer. The lysate was incubated on the resin for 1 hour at 4
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°C while rotating. His6-GatCAB was purified according to the manufacturer's protocol
(Gold Biotechnology).
5.4.5 In vitro transcription and quantification of S. aureus tRNAAsn
The S. aureus tRNAAsn plasmid was synthesized by GenScript (GenScript Biotech
Corp. Piscataway, NJ). The gene was synthesized with a 5’-T7 RNA polymerase
promoter sequence and a 3’-BstNI site and then sub-cloned into the pUC57 vector. Since
the tRNAAsn sequence starts with uracil (U), a hammerhead ribozyme sequence was
added between the T7 RNA polymerase promoter sequence and the start of the tRNA Asn
DNA sequence. This vector design allows run-off transcription of the BstNI-digested
plasmid DNA to produce tRNAAsn with a 5’-hammerhead ribozyme sequence (145-146).
After transcription, the hammerhead ribozyme reaction cleaves the transcript to provide
the unmodified tRNAAsn transcript with its native 5’-U base.
The tRNAAsn plasmid was transformed into DH5 calcium chloride competent cells
and the plasmid was isolated from a saturated overnight culture in LB medium
supplemented with ampicillin (~50-200 mL, 100 g/mL) using the E.Z.N.A.® Plasmid Maxi
kit (Omega Bio-Tek, Norcross, GA). The eluted DNA sample was concentrated by
isopropanol precipitation.
All buffers used in this section were made with DEPC-treated water. BstNI
digestion of the tRNAAsn plasmid DNA (1 g/L) was carried out in NEB 3.1 buffer (1×)
with BstNI (0.1 units//L). The digestion was performed at 60 °C overnight. The digested
plasmid DNA was extracted with phenol/chloroform (1:1 v/v, pH 7-8) and isopropanol
precipitated.
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The transcription reactions were performed in buffer containing Tris-HCl (40 mM
pH 8.1), spermidine (1 mM), DTT (5 mM), NTP (1 mM each), BSA (5 g/mL), inorganic
pyrophosphatase (0.45 U) and 30 mM MgCl2 (146). Transcription was carried out using 1
g/L of the BstNI-digested plasmid and 5 M T7 RNA polymerase at 30 °C for 2 hours.
The hammerhead ribosome reaction was performed as previously described (145) over
two hours. After phenol/chloroform (1:1 v/v, pH ~4.3) extraction and isopropanol
precipitation, the tRNA was purified on a denaturing urea gel (8% acrylamide and 9 M
urea). The tRNAAsn band was excised from the gel, crushed, and incubated in crush and
soak buffer (0.5 mM NH4OAc pH 5.2, 1 mM Na2EDTA) rotating at 37 °C overnight. The
eluted tRNAAsn sample was isopropanol precipitated and the resultant pellet was
dissolved in water.
The tRNAAsn sample was refolded in the presence of MgCl2 (2 mM) and quantified
using S. aureus ND-AspRS as previously described (49).
5.4.6 32P/nuclease P1 GatCAB transamidation assays
The 3’-end of the S. aureus tRNAAsn was labeled with -32P-AMP and
aminoacylated as previously described (73). (The plasmid overexpressing the CCAadding enzyme was provided by Dr. Rebecca Alexander, Wake Forest University).
P1 nuclease transamidation assays were performed as previously described (73).
GatCAB (10 nM) with or without Sa2591 (500 nM) was pre-equilibrated with 40 mM
HEPES-KOH (40 mM), pH 7.5, MgCl2 (8 mM) and KCl (25 mM) on ice for 15 min.

32P-

labeled Asp-tRNAAsn (5 mM) was added and the reaction was initiated with ATP (4 mM)
and glutamine (2 mM) at 37 °C. The digested samples were spotted on a prewashed,
dried PEI-cellulose TLC plates (Sigma-Aldrich, St. Louis, MO). The TLC was developed
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in running buffer (25 mM NH4OAc, 5% acetic acid). The plates were imaged overnight
and quantified by phosphoimager.
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CHAPTER 6
CONCLUSIONS AND FUTURE DIRECTIONS
6.1 Introduction
This dissertation work focused on the functional characterization of accessory
proteins and novel activities of enzymes involved in direct and indirect tRNA
aminoacylation. Chapter 2 described the first characterization of the M. smegmatis Asntransamidosome. Chapter 3 focused on the discovery of an unexpected enzymatic activity
of bacterial AspRSs, namely the synthesis of Glu-tRNAGln by these enzymes. Chapter 4
summarized efforts to more effectively overexpress and purify untagged or cleavable
tagged Hp100 constructs. Chapter 5, the preliminary characterization of a truncated
ortholog of Hp0100 called Sa2591 from S. aureus were discussed.
Since proteins play critical roles in structure, function, and regulation in cells, it is
important to maintain high fidelity during protein synthesis. The first step in protein
synthesis is the pairing up of the cognate tRNA to its cognate amino acid. This
esterification reaction is catalyzed by a group of enzymes called the aaRSs (3, 11, 13,
147). Since organisms contain twenty different amino acids, there should be at least 20
aaRSs, one for each aa-tRNA isoacceptor pair. This scenario holds true in eukaryotes,
and some microorganisms like E. coli (30). However, many prokaryotes do not have a full
set of 20 aaRSs (11, 15, 32). In fact, many organisms lack AsnRS and/or GlnRS and use
a two-step, indirect tRNA aminoacylation pathway to produce Asn-tRNAAsn and GlntRNAGln, respectively (15, 34, 36, 43).
The work presented in this dissertation focused on three different pathogenic
bacteria: H. pylori, M. smegmatis, and S. aureus. Among these three bacteria, H. pylori
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and M. smegmatis both lack genes encode for AsnRS and GlnRS and therefore utilize
indirect tRNA aminoacylation to produce Asn-tRNAAsn and Gln-tRNAGln (42, 49-50). S.
aureus does not contain a GlnRS, so it uses the indirect route to produce Gln-tRNAGln
(48). Further, S. aureus also lacks AsnS and hence cannot biosynthesize asparagine in
the absence of tRNA. Therefore, in S. aureus, asparagine synthesis also occurs via this
indirect tRNA aminoacylation pathway (51).
The first step in indirect aminoacylation of Asn-tRNAAsn is the aspartylation of
tRNAAsn to produce the misacylated product Asp-tRNAAsn by ND-AspRS. Next, this
misacylated Asp-tRNAAsn is transaminated to Asn-tRNAAsn by an amidotransferase called
GatCAB. An analogous, two-step process exists to produce Gln-tRNAGln. In this case,
ND-GluRS (or GluRS2 in H. pylori) misacylates tRNAGln to produce Glu-tRNAGln, which is
then converted to Gln-tRNAGln by the same GatCAB. In these organisms, it is necessary
to prevent the misacylated-tRNAs, Asp-tRNAAsn and Glu-tRNAGln, from entering the
ribosome, which would lead to translational errors by incorporating aspartate and
glutamate into asparagine and glutamine codons respectively (49, 53, 148). Mechanism/s
for the quick delivery of misacylated-tRNAs, either from ND-AspRS or ND-GluRS to
GatCAB must exist to ensure the fidelity of protein synthesis.
One such mechanism is the formation of a ribonucleoprotein complex called
transamidosome (77-82). For example, T. thermophilus, a thermophilic bacterium
assembles a stable ribonucleoprotein complex composed of four tRNA Asn, two GatCAB,
and two dimeric ND-AspRS. This complex is called the Asn-transamidosome and it
protects the aminoacyl ester linkage in Asp-tRNAAsn and ensures efficient production of
Asn-tRNAAsn (77, 82). There are only a few examples of Gln-transamidosome
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characterized so far. The T. maritima Gln-transamidosome is composed of one tRNAGln,
one GatCAB, and one monomeric ND-GluRS (81). But compared to the Asntransamidosomes, these Gln-transamidosomes are less stable and more dynamic in
nature and may not be physiologically relevant.
Unlike the above mentioned thermophilic transamidosomes, the mesophilic H.
pylori Asn-transamidosome requires a novel protein partner, Hp0100, instead of tRNAAsn,
for stable assembly (79). Hp0100 is not only involved in making a stable transamidosome,
but it also accelerates both GatCAB-catalyzed transamidation reactions. The addition of
Hp0100 increases Asp-tRNAAsn transamidation by ~35-fold (79) and Glu-tRNAGln
transamidation by ~3-fold (87). Further, Hp0100 contains two ATPase domains: an
adenosine nucleotide alpha hydrolase (AANH) domain and a P-loop motif. Hp0100
hydrolyzes ATP to ADP and Pi, and this ATP hydrolysis is enhanced in the presence of
either Asp-tRNAAsn or Glu-tRNAGln. Analysis of mutations in the two ATPase domains
demonstrated that both are catalytically active and the AANH domain activity is
specifically accelerated by Glu-tRNAGln while the P-loop responds to Asp-tRNAAsn (87).
Hp0100 also contain several, clustered, conserved cysteine residues, including a possible
metal binding motif with CXXC signature sequence in the P-loop ATPase domain. Figure
6.1 summarizes the findings on Hp0100 so far.
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Figure 6.1. Hp0100 is a multi-functional protein. Hp0100 is a component of the H.
pylori Asn-transamidosome. Hp0100 enhances the transamidation of both Asp-tRNAAsn
and Glu-tRNAGln to Asn-tRNAAsn and Gln-tRNAGln, respectively. It has two ATPase
domains: AANH and P-loop, which are specifically activated by the two misacylated
tRNAs. Hp0100 also contains a metal binding motif with a CXXC consensus sequence.
6.2 The components of the indirect tRNA aminoacylation pathway of M. smegmatis
assemble into an Asn-transamidosome
We have demonstrated that the overexpressed and purified M. smegmatis
GatCAB from M. smegmatis mc2-155 co-purifies with endogenous ND-AspRS. Standard
aminoacylation assays clearly showed that the co-purified ND-AspRS is active in the Asntransamidosome complex form (Figure 2.3 and 2.4). To our knowledge, the copurification of M. smegmatis GatCAB and ND-AspRS represents the first Asntransamidosome isolation from Mycobacteria
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Mycobacteria is the only bacterial clade that exhibits a clear connection between
indirect tRNA aminoacylation and mistranslation leading to persistence (76). It would be
useful to investigate the composition of the M. smegmatis transamidosome in more detail.
Are there two separate Asn and Gln-transamidosomes or do these proteins all assemble
into one larger ribonuclear protein complex? Is complex formation tRNA-dependent or
does it require another protein partner in a manner similar to that of Hp0100 (79)? Will
the composition of the transamidosome vary under mistranslation induces conditions?
These questions are worth investigating in the future.
6.3 M. smegmatis GatCAB co-purified with other putative accessory proteins
We have identified two putative accessory proteins that repeatedly co-purified with
M. smegmatis GatCAB. The two proteins that were identified were a universal stress
protein (USP, MSMEG3950) and superoxide dismutase (SOD) (Figure 2.1). Both are
stress-related proteins (110-111). We hypothesize that these proteins may disrupt
transamidosome formation in response to external stressors and result in mistranslation
providing conditions beneficial for the organism’s survival. It would be interesting to
confirm the observed interactions between these proteins and the M. smegmatis
transamidosome and to test the strength of these interactions under different stressrelated growth conditions to see if a connection between stress, growth, and persistence
can be identified.
6.4 Some bacterial AspRSs exhibits GluRS like activity
We have discovered that some bacterial AspRSs and ND-AspRSs display
considerable GluRS activity. These AspRSs are capable of aminoacylating tRNAGlu with
glutamate to produce Glu-tRNAGlu. This activity is interesting as these enzymes do not
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glutamylate their “natural” substrates tRNAAsp and tRNAAsn to produce Glu-tRNAAsp or
Glu-tRNAAsn respectively (Figure 3.11B). Further, these AspRSs are incapable of putting
aspartate onto tRNAGlu as well (Figure 3.11A). This unexpected GluRS-like activity is
noteworthy because it is accurate and the product does not put the genetic code into
jeopardy. We believe that this activity is a remnant of early AspRS evolution. Future
research should focus on identifying the molecular recognition elements in tRNA Glu that
allow for efficient glutamylation by ND-AspRS while discriminating against the
misacylated species mentioned above. An important question is: How do these AspRS
enzymes know to only put Glu onto tRNAGlu? This observation suggests an intriguing,
subtle communication process.
6.5 Hp0100 and Sa2591 are involved in indirect tRNA aminoacylation and exhibit
different activities under different growth conditions
Although full-length orthologs of Hp0100 are found only in -proteobacteria,
truncated orthologs of Hp0100 have been found in many other bacteria in different clades.
These truncated versions contain roughly 2/3 of the primary N-terminal sequence of
Hp0100 and contain both ATPase domains (Figure 5.1).
Working with full-length His6-Hp0100 proved to be challenging for several reasons:
potential complications with respect data interpretation with the His6-tagged Hp0100 due
to the metal-binding nature of this tag and the metal-binding motif in Hp0100; challenges
purifying His6-Hp0100 due to solubility issues; and the co-purification of E. coli AspRS
with His6-Hp0100 (87). None of the strategies undertaken to better overexpress and purify
Hp0100 were successful. Due to these difficulties in working with the full-length Hp0100,
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we focused on characterizing the truncated ortholog of Hp0100, Sa2591 from S. aureus,
which proved to be more reliably easy to handle and manipulate.
The preliminary characterizations of Sa2591 by Dr. Whitney Wood highlight the
involvement of Sa2591 in possible Asn-transamidosome formation. She demonstrated
that Sa2591 hydrolyzes ATP to ADP and Pi and that this ATPase activity is enhanced in
the presence of misacylated tRNAs (138). However, as demonstrated in Figure 5.6 in
chapter 5, Sa2591 impact the transamidation activities of GatCAB, in contrast to the
impact of Hp0100. Since these data were obtained with in vitro transcribed tRNAs, this
loss of transamidation enhancement of GatCAB by Sa2591 may due to the lack of posttranscriptional modifications on the tRNAs. With the recent identification of Sa2591 and
Hp0100 as epoxyqueuosine reductases (99), we think that these proteins may be
screening tRNAAsn for the presence of queuosine. Thus, we hypothesize that these two
proteins promote transamidation in fully-modified tRNAs, but are coopted for queuosine
biosynthesis when needed.
Overall, we think that these accessory proteins Hp0100 and Sa2591 have different
activities under different growth environments (Figure 6.2). Under healthy growth
conditions, these proteins will promote stable Asn-transamidosome assembly, encourage
biosynthesis of Asn-tRNAAsn, and ensure the insertion of asparagine into proteins at
asparagine codons during protein translation. Under stressful growth conditions, Hp0100
and Sa2591 would dissociate from the Asn-transamidosome, resulting in an accumulation
of misacylated Asp-tRNAAsn and insertion of aspartate into asparagine codons. This
mistranslation may beneficial to the organisms for survival under stress related
conditions. This hypothesis is supported by the discovery of misincorporation of aspartate
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into asparagine codons in Mycobacteria, which facilitated adaptive rifampicin-specific
phenotypic resistance (76). Moreover, after leaving the transamidosome free Hp0100 and
Sa2591 could also upregulate queuosine biosynthesis. This theory is backed by the
recent discoveries of increased levels of modified tRNAs under stress-induced conditions
(143) and the increase in Sa2591 mRNA levels in S. aureus in respond to pH changes
(144). Further experiments need to be carried out to validate this hypothesis.
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Figure 6.2. Schematic representation of the role of Hp0100 and Sa2591 under
different growth conditions. Under healthy growth conditions, Hp0100 and Sa2591
would promote Asn-transamidosome assembly, which would lead to the biosynthesis of
Asn-tRNAAsn and accurate translation. In a stressed environment, the Asntransamidosome would dissociate, causing the production of Asp-tRNAAsn and
mistranslation. Hp0100 and Sa2591 would then act as epoxyqueuosine reductase and
increase the levels of tRNA modifications in cells.
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APPENDIX A
EFFECT OF EXOGENOUS AMMONIA ON THE TRANSAMIDASE ACTIVITY OF WT
AND D185 GATCAB VARIANTS
The work presented in this appendix is included here because it is unrelated to the rest
of the work presented in this dissertation and is the result of a side project. Reproduced
with permission from Zhao, L.; Rathnayake, U. M.; Dewage, S. W.; Wood, W. N.; Veltri,
A. J.; Cisneros, G. A.; and Hendrickson, T. L. Characterization of tunnel mutants reveals
a catalytic step in ammonia delivery by an aminoacyl-tRNA amidotransferase. FEBS Lett.
2016, 590, 3122-3132. Copyright © 2016, John Wiley and Sons, reprinted with
permission.
A.1 Introduction
In H. pylori and other organisms that do not have AsnRS and/or GlnRS, the
production of Asp-tRNAAsn and Gln-tRNAGln occurs through an indirect tRNA
aminoacylation pathway (34, 36-37, 43). In this pathway, the misacylated intermediates
Asp-tRNAAsn and Glu-tRNAGln are converted to Asn-tRNAAsn and Gln-tRNAGln by a
glutamine-dependent amidotransferase called GatCAB (34, 37, 44). GatCAB is
composed of three subunits GatA, GatB, and GatC.
GatCAB catalyzes three discrete reactions (Chapter 1, Figure 1.5) (37, 71, 73).
GatA hydrolyzes glutamine to produce glutamate and ammonia. The ammonia is then
delivered to the active site of GatB through an unusually hydrophilic ammonia tunnel (~40
Å). GatB catalyzes the ATP-dependent phosphorylation of Asp-tRNAAsn and Glu-tRNAGln,
followed by the delivery of the ammonia from GatA to convert phosphoryl-Asp-tRNAAsn
and phosphoryl-Glu-tRNAGln into Asn-tRNAAsn and Gln-tRNAGln respectively (37, 71, 73).
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There are two proposed ammonia tunnels in S. aureus GatCAB, tunnel I (60) and
tunnel II (70). While the proposed tunnel I is hydrophilic in nature, tunnel II is mostly lined
with hydrophobic residues. Nakamura and coworkers proposed that ammonia delivery
through the hydrophilic tunnel I occurs via a series of protonation and deprotonation steps
(60). The D185 residue of H. pylori GatCAB is located at the top of this tunnel and may
serve as the first catalytic residue in this proton relay process acting as an acid and a
base. Dr. Liangjun Zhao carried out the characterization of this D185 residue in wild-type
GatCAB and D185A, D185E, and D185N mutations (73). He monitored the participation
of these residues in the three reactions catalyzed by GatCAB: glutamine hydrolysis,
phosphorylation of Glu-tRNAGln, and transamidation to produce Gln-tRNAGln (73). My
work focused on the characterization of the transamidation reaction of WT GatCAB and
these D185 tunnel mutants with ammonium chloride as the ammonia donor (instead of
glutamine).
A.2 Results
According to the data from Dr. Liangjun Zhao, the D185A and D185N GatCAB
mutants exhibit reduced glutamine hydrolysis and phosphorylation activities compared to
WT GatCAB (73). In contrast, the transamidation activities of these two mutants were
almost completely disrupted when glutamine was used as the source of ammonia (2%
and 6% of WT, respectively, Figure A.1). It is highly unlikely that the partial reductions in
initial rates for glutamine hydrolysis and phosphorylation account for the dramatic
decrease in transamidase activity observed. In contrast, the D185E GatCAB mutant
maintained robust transamidase activity (107% of the WT, Figure A.1), in addition to
glutaminase and kinase activities. The fact that D185E GatCAB, but not D185N GatCAB
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retains WT transamidation activity directly points to a requirement for an ionizable
carboxylate/carboxylic acid side chain.

Figure A.1. The use of glutamine as an ammonia source for WT and D185 GatCAB
mutants. (A) Initial rates of transamidation of WT and D185 mutants with glutamine.
Results are shown for WT (●), D185A (■), D185E (), and D185N (). Assays were
carried out with 1 nM GatCAB and 5 mM glutamine. (B) Bar graph representation of
relative activities of the initial rates for the transamidation of Glu-tRNAGln to Gln-tRNAGln
by WT GatCAB and D185 mutants. Error bars represent standard deviation from
biological triplicates (***P < 0.001). Figure provided by Dr. Liangjun Zhao and republished
with permission (73).
Many glutamine-dependent amidotransferases, including GatCAB (44), can utilize
exogenous ammonia as a substrate replacing glutamine hydrolysis. We compared rates
of ammonia utilization between WT GatCAB and our D185 mutations with Glu-tRNAGln as
a substrate (Figure A.2). WT GatCAB utilizes ammonia as the ammonia donor at a rate
that is 0.8% that observed with glutamine. As with our other assay results, the activity of
the D185E GatCAB variant resembles the WT enzyme with an ammonia-dependent rate
of transamidation that is 117% that of WT. Surprisingly, the D185A GatCAB variant also
uses ammonia as a substrate (56% activity compared to WT), while the D185N mutation
is much less active in the presence of ammonia (14% compared to WT). These results
differentiate the activities of D185A GatCAB from D185N GatCAB. The initial rates and
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transamidase activity with glutamine and exogenous ammonia of WT and GatCAB
mutants are summarized in Table A1.

Figure A.2. The use of ammonium chloride as an ammonia source for WT and D185
GatCAB mutants. (A) Initial rates of transamidation of WT and D185 mutants with NH4Cl.
Results are shown for WT (●), D185A (■), D185E (), and D185N (). Assays were
carried out with 100 nM GatCAB and 20 mM NH4Cl. (B) Bar graph representation of
relative activities of the initial rates for the transamidation of Glu-tRNAGln to Gln-tRNAGln
by WT GatCAB and D185 mutants. Error bars represent standard deviation from
biological triplicates (**P < 0.01, ***P < 0.001). Figure republished with permission (73).
Table A.1. Initial rates for transamidation of WT and D185 GatCAB variants with
NH4Cl as ammonia donor.

Transamidase with glutamine
GatCAB

Transamidase with NH4Cl

Initial rate
(M/min)

Enzyme
activity*
(s-1)

Initial rate
(M/min)

Enzyme
activity*
(s-1)

WT

0.270 ± 0.015

4.50 ± 0.25

0.214 ± 0.012

0.036 ± 0.002

D185A

0.005 ± 0.001

0.08 ± 0.02

0.122 ± 0.020

0.020 ± 0.003

D185E

0.288 ± 0.020

4.80 ± 0.34

0.253 ± 0.040

0.042 ± 0.007

D185N

0.015 ± 0.002

0.26 ± 0.03

0.031 ± 0.018

0.005 ± 0.003

*Enzyme activity is defined as the initial rate divided by enzyme concentration (1 nM with
glutamine and 100 nM with NH4Cl).
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A.3 Discussion
To characterize the importance of the D185 residue in the GatA subunit of GatCAB
in ammonia transport, this residue was mutated to alanine, glutamate, and asparagine.
The three enzyme reactions catalyzed by GatCAB: glutaminase, phosphorylation of tRNA
and transamidase, were examined experimentally to compare the behavior of WT
GatCAB to its D185A, D185N, and D185E variants.
The D185E GatCAB variant retained WT-like activity for all three reactions. The
D185A and D185N GatCAB mutants had reductions in glutamine hydrolysis and
phosphorylation compared to WT and their transamidation activities were almost
completely disrupted when glutamine was used as the source of ammonia (73). It is highly
unlikely that the partial reductions in initial rates for glutamine hydrolysis and
phosphorylation account for the dramatic decrease in transamidase activity observed.
Unexpectedly, when we replaced glutamine with ammonium chloride as the source
of ammonia and compared the activities of these D185 variants (Figure A.2), differences
between the D185A and D185N mutations were unmasked. The D185N GatCAB was
essentially insensitive to the source of ammonia; when either glutamine or ammonium
chloride was used as the substrate for transamidation, observed transamidation rates
were 6% and 14% that of WT, respectively. In contrast, D185A GatCAB utilized ammonia
as a substrate with a rate that was 56% that of WT, in stark contrast to the 2% of WT
activity that was observed when this mutant was assayed with glutamine as the ammonia
source.
To explain this divergence between the D185A and D185N GatCAB variants with
ammonium chloride as an exogenous ammonia source, we considered two scenarios:
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these mutations could differentially hinder accessibility of ammonia to the GatCAB
ammonia tunnel through GatA (scenario 1) or ammonia could passively diffuse into the
GatB active site (scenario 2). The data herein strongly favor the first scenario, wherein
ammonia access to the GatB active site is only (or predominantly) achieved via migration
through the ammonia tunnel.
Scenario 2 considers the possibility that ammonia can passively diffuse into the
GatB active site, without migration through that GatCAB ammonia tunnel. In this case,
one would expect the initial transamidation rates of all four D185 GatCAB variants
(including WT) to be nearly indistinguishable from each other with ammonium chloride as
the sole source of ammonia for transamidation. Instead, significant differences were
observed in these transamidation rates. The WT and D185E GatCAB variants both use
ammonium chloride with initial rates just under 1% observed with glutamine (Table A1),
and the D185N GatCAB has an ammonium chloride-dependent rate of transamidation
that is only 2% that of the corresponding glutamine-dependent initial rate. In stark
contrast, the impact of switching from glutamine to ammonium chloride is much less
dramatic with the D185A GatCAB mutant: this mutant enzyme retains 25% of its
glutamine-dependent, initial rate of transamidation when ammonium chloride is used
instead. The broad range of the transamidase activity ratios comparing ammonium
chloride to glutamine (from 0.1% to 25%) strongly argues against passive diffusion of
ammonia into the GatB active site (scenario 2).
The significant loss of transamidase activity using exogenous ammonia donor
(versus glutamine) suggests that the usable exogenous ammonia has to be transferred
through the internal ammonia tunnel (scenario 1). The differences between the D185A
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and D185N GatCAB variants with ammonium chloride as the substrate are subtle
because both of these enzymes are already globally defective in transamidation as
demonstrated when glutamine is used as the native substrate (Figure A.1). With the
D185A mutant, the higher rate of transamidation with ammonium chloride results from the
small alanine side chain, which presumably widens the tunnel and allows some ammonia
migration to occur in the absence of glutamine bound to GatA. Nevertheless, the D185A
mutation still suffers a huge ammonia transfer energy penalty in the absence of the
carboxyl group (similar to the D185N variant) as indicated by its low transamidase activity
with glutamine as the ammonia donor.
In conclusion, the D185 residue was characterized, and the results revealed a
probable step in the ammonia delivery mechanism for GatCAB. The differences between
the WT-like D185E GatCAB and the defective D185A and D185N mutants support our
hypothesis that D185 acts as an acid/base residue for ammonia transfer during catalysis.
A.4 Materials and Methods
A.4.1 Materials
L-glutamic acid, magnesium chloride, triton X-100, nuclease P1, and PEI-cellulose
thin layer chromatography plates were from were purchased from Sigma-Aldrich (St.
Louis, MO). All radiolabeled reagents were purchased from American Radiolabeled
Chemicals

(St.

Louis,

ethylenediaminetetraacetic
thiogalactopyranoside

MO).
acid

(IPTG),

Ampicillin,

(EDTA),

chloramphenicol,

guanidine

tris(hydroxymethyl)

thiocyanate,
aminomethane

kanamycin,
isopropyl -D(Tris),

and

phenylmethanesulfonyl fluoride (PMSF) were from Gold Biotechnology, Inc. (St. Louis,
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MO). Sodium chloride (NaCl), and ammonium acetate (NH4OAc) were purchased from
Fisher Scientific (Hampton, NH).
A.4.2 Overexpression and purification of WT GatCAB and D185 mutants
WT GatCAB and D185 variants were overexpressed and purified as previously
described (71).
A.4.3 In vivo transcription and purification of H. pylori tRNAGln
H. pylori tRNAGln was overexpressed in E. coli MV1184. LB medium supplemented
with ampicillin (100 g/mL) was inoculated with a saturated culture grown from a single
colony in the same medium. Cultures were incubated at 37 ˚C, 200 rpm and
overexpression was induced with IPTG (1 mM) when OD600 reached 0.4-0.6. The cells
were pelleted by centrifugation at 4000 rpm at 4 ˚C for 10 min after 4 hours. The cell
pellet was suspended in W1 buffer (50 mM Tris-acetate, pH 7.8, 4 M guanidine
thiocyanate, 15 mM -mercaptoethanol, and 2% triton X-100). After incubating on ice for
15 min, NaOAC (3 M, pH 6.5, 1:1 v/v) was added and the mixture was incubated on ice
for an additional 15 minutes. The cell debris was removed by centrifugation at 10,000 g
for 20 min. The lysate was isopropanol precipitated and the resulting pellet was dissolved
in W4 buffer (10 mM Tris-acetate, pH 7.8 and 1 mM Na2EDTA). The solution was
phenol/chloroform (1:1 v/v, pH 4.3) extracted several times to remove contaminating
proteins. The tRNA sample was isopropanol precipitated and the pellet was resuspended
in water and deacylated in 100 mM Tris-HCl (pH 9) for 20 min at 37 ˚C. These
purifications yield tRNA that is enriched with the overexpressed H. pylori tRNAGln
isoacceptor but also contains total E. coli tRNA.
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A.4.4 32P/nuclease P1 GatCAB transamidation assays
The 3’-end of H. pylori tRNAGln was labeled with -32P-AMP and aminoacylated as
previously described (149). The plasmid overexpressing the CCA-adding enzyme was
provided by Dr. Rebecca Alexander.
The P1 nuclease transamidation assays were performed essentially as described
in chapter 5, with the exception of using GatCAB (100 nM),

32P-labeled

Glu-tRNAGln (10

M), and NH4Cl (20 mM) instead of glutamine. The TLC was developed in running buffer
(100 mM NH4OAc, and 5% acetic acid). The plates were imaged overnight and quantified
by phosphoimager.
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ABSTRACT
FUNCTIONAL CHARACTERIZATION OF ACCESSORY PROTEINS AND NOVEL
ACTIVITIES IN DIRECT AND INDIRECT TRNA AMINOACYLATION
by
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Degree: Doctor of Philosophy
Indirect tRNA aminoacylation is essential for most bacteria and archaea,
particularly when these species do not have genes encoding asparaginyl- and/or
glutaminyl-tRNA synthetase (AsnRS and GlnRS). In the absence of AsnRS, the first step
in Asn-tRNAAsn synthesis involves misacylation of tRNAAsn with aspartate to produce AsptRNAAsn; this reaction is catalyzed by a non-discriminating aspartyl-tRNA synthetase (NDAspRS). Subsequently, in bacteria, an amidotransferase called GatCAB converts AsptRNAAsn to Asn-tRNAAsn. An analogous, two-step processes exist to produce Gln-tRNAGln.
In this case, a non-discriminating glutamyl-tRNA synthetase (ND-GluRS) misacylates
tRNAGln to produce Glu-tRNAGln, which is then converted to Gln-tRNAGln by GatCAB. The
central hub of the indirect tRNA aminoacylation pathway is the formation of a
macromolecular complex called the transamidosome.
In Helicobacter pylori, the pathogenic bacterium that causes stomach ulcers and
gastric cancers, Asn-transamidosome formation requires a protein partner called
Hp0100, to form a stable, tRNA-independent complex. Hp0100 accelerates the GatCABcatalyzed transamidation of Asp-tRNAAsn into Asn-tRNAAsn ~35 fold and of Glu-tRNAGln
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into Gln-tRNAGln ~3 fold. Our preliminary evidence suggests that Hp0100 contains two
mutually exclusive ATP hydrolase domains, which are activated by Glu-tRNAGln and AsptRNAAsn, respectively.
This dissertation work focusses on four different but connected projects. Chapter
2 discusses the characterization of the Mycobacterium smegmatis Asn-transamidosome.
Overexpression of GatCAB in M. smegmatis, a benign, close relative of Mycobacterium
tuberculosis, and its purification resulted in the co-purification of ND-AspRS and several
other proteins. These results represent the first successful purification of a Mycobacterial
Asn-transamidosome from its native organism. Efforts to determine if ND-GluRS also copurified with GatCAB were inconclusive. Two of the unknown proteins that reproducibly
co-purify with GatCAB were identified as a universal stress protein (USP) and superoxide
dismutase (SOD), which are stress-related proteins. Chapter 3 focuses on the discovery
of an unexpected enzymatic activity of AspRSs. We discovered that some bacterial,
discriminating AspRS (E. coli) and ND-AspRSs (H. pylori, M. smegmatis, and
Staphylococcus aureus) are capable of aminoacylating E. coli tRNAGlu with glutamate to
produce correctly aminoacylated Glu-tRNAGlu without glutamylating their “natural” tRNAs
(tRNAAsp and tRNAAsn). Chapter 4 summarizes our efforts to optimize the overexpression
and purification of Hp100 without a metal-binding tag. Finally, we have identified truncated
orthologs of Hp0100 in several other pathogenic bacteria outside this clade. Chapter 5
reports our preliminary characterization of a truncated ortholog of Hp0100 called Sa2591
from S. aureus. Sa2591 shares some functional similarities with Hp0100 and may be a
sensor for the presence of post-transcriptional modifications in tRNAAsn.
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